Role of neutrophils in the imiquimod (IMQ)-induced mouse model of psoriasis by Bevilacqua, Dalila
  
 
UNIVERSITA‟ DEGLI STUDI DI VERONA 
 
DIPARTIMENTO DI  
 
MEDICINA 
 
 
SCUOLA DI DOTTORATO DI 
 
SCIENZE DELLA VITA E DELLA SALUTE 
 
 
DOTTORATO DI RICERCA IN 
 
INFIAMMAZIONE, IMMUNITA’ E CANCRO 
 
 
 
XXX CICLO / 2014 
 
 
TITOLO DELLA TESI DI DOTTORATO 
 
Role of Neutrophils in the Imiquimod (IMQ)-induced mouse model of Psoriasis 
 
S.S.D. MED/04 
 
 
Coordinatore:   
Prof./ssa Constantin Gabriela 
 
    
 
Tutor:    
Dott./ssa  Scapini Patrizia 
   
       
 
 
  Dottorando:   
  Dott./ssa  Bevilacqua Dalila 
 
  
 
 
 
 
 
 
 
 
 
 
 
Quest’opera è stata rilasciata con licenza Creative Commons Attribuzione – non commerciale 
Non opere derivate 3.0 Italia . Per leggere una copia della licenza visita il sito web: 
http://creativecommons.org/licenses/by-nc-nd/3.0/it/ 
Abstract 
 
 
Psoriasis is a chronic skin disease associated with deregulated interplays between 
immune cells and keratinocytes. Neutrophil accumulation in the skin is one of the 
histological features that characterize psoriasis. However, the role of neutrophils 
in psoriasis development remains poorly understood. In this study, we utilized the 
imiquimod (IMQ)-induced mouse model of psoriasis to elucidate the specific 
contribution of neutrophils to psoriasis development. We report that neutrophils 
act as negative modulators of disease propagation and exacerbation by inhibiting 
δ T cell effector functions via NADPH oxidase-mediated reactive oxygen species 
(ROS) production, as revealed by analysing disease development/progression in 
neutrophil-depleted mice. We also report that Syk functions as crucial molecule 
mediating neutrophil and δ T cell interactions. In support of the latter findings, 
we demonstrate that the selective impairment of Syk-dependent signalling in 
neutrophils only, is sufficient to reproduce the enhancement of skin inflammation 
and δ T cell infiltration observed in neutrophil-depleted mice. Overall, our 
findings add new insights into the specific contribution of neutrophils to disease 
progression in the IMQ-induced mouse model of psoriasis. Considering that, 
similarly to mouse psoriasis, the important role of IL-17 producing γδ T cells in 
human psoriasis has just started to emerge, it is likely that inhibitory crosstalk 
between neutrophils and γδ T cells may exist also in human psoriasis. Neutrophils 
may indeed act as unexpected negative players of disease development in specific 
types or clinical stages of human psoriasis. Consequently, also the utilization of 
therapeutic interventions targeted to inhibit neutrophil functions should be 
carefully evaluated. 
 
 
 
 
Sommario 
 
 
La psoriasi è un‟infiammazione cronica e recidivante della pelle, caratterizzata da 
un‟alterata interazione tra sistema immunitario e cheratinociti. Nonostante 
l‟infiltrazione dei granulociti neutrofili nella pelle sia una peculiarità della 
patologia psoriatica, il ruolo di queste cellule nella psoriasi non è ancora ben noto. 
In questa tesi, per studiare il ruolo dei neutrofili nella psoriasi abbiamo utilizzato 
un modello murino di psoriasi indotta dall‟applicazione topica di imiquimod 
(IMQ), insieme alla somministrazione di un anticorpo specifico per la deplezione 
dei neutrofili. I risultati ottenuti in questo studio, hanno mostrato che i neutrofili 
possono interferire con la progressione della patologia inibendo in maniera 
specifica i linfociti T γδ, principali mediatori di infiammazione in questo modello 
sperimentale di psoriasi. I dati da noi ottenuti dimostrano che i neutrofili 
inibiscono la proliferazione e la produzione di IL-17 da parte dei linfociti T γδ 
tramite la produzione di specie reattive dell'ossigeno (ROS), indotta 
dall'attivazione del complesso enzimatico NADPH ossidasi. Inoltre, abbiamo 
dimostrato che tale meccanismo inibitorio è contatto dipendente e richiede 
l‟interazione specifica neutrofilo-linfocita T γδ. Infine, abbiamo identificato la 
chinasi Syk quale molecola cruciale implicata nella modulazione di questa 
capacità dei neutrofili di inibire i linfociti T γδ. Infatti, l‟assenza specifica di Syk 
nei neutrofili è risultata sufficiente per riprodurre il fenotipo osservato con la 
deplezione completa dei neutrofili nel modello di psoriasi indotta da IMQ. 
L‟insieme dei dati ottenuti contribuiscono quindi alla comprensione del ruolo del 
neutrofilo nel modello murino di psoriasi indotta dall‟applicazione topica di 
imiquimod. Come per il modello murino, la possibile rilevanza patogenetica dei 
linfociti T γδ sta emergendo anche nella psoriasi umana. E‟ quindi ipotizzabile 
che interazioni inibitorie tra i neutrofili e i linfociti T γδ possano essere importanti 
anche nello sviluppo di psoriasi nell‟uomo. I neutrofili potrebbero infatti 
esercitare un inaspettato ruolo di modulazione negativa nell‟evoluzione 
dell‟infiammazione psoriatica. Conseguentemente, l‟utilizzo di terapie mirate 
all‟inibizione delle funzioni effettrici dei neutrofili nella psoriasi dovrebbe essere  
valutato con cautela.  
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1.  Introduction 
 
 
 
Psoriasis: general features  
 
1.1  Epidemiology 
Psoriasis is a common immune-mediated chronic skin disease that occurs in 
genetically predisposed individuals with an overall prevalence of 2% to 3% of the 
world's population (Christophers 2001). Psoriasis exhibits a bimodal distribution 
with a peak between 15 and 30 years and another between 50 and 60 years 
(Raychaudhuri & Gross 2000). Crucial traits of psoriasis, such as the high 
prevalence, chronicity, comorbidity and the resulting visible impact on physical 
appearance, make it a disorder with both a physical and psychological burden 
(Kimball et al. 2005). Individuals with psoriasis have indeed also an increased risk 
of developing other chronic and serious health diseases. These so-called comorbid 
diseases include psoriatic arthritis, the metabolic syndrome, cardiovascular 
disorders, as well as numerous other diseases such as anxiety/depression, non-
alcoholic fatty liver disease, Crohn‟s disease, or lymphoma (Griffiths & Barker 
2007; Nestle et al. 2009). 
 
1.2  Histological hallmarks  
Psoriasis is characterized by different clinical phenotypes and its classification is 
complex and it is therefore out of the scope of this thesis. Chronic plaque psoriasis 
(psoriasis vulgaris) is the most common form of the disease, accounting for about 
90% of cases (Boehncke & Schön 2015). Chronic plaque psoriasis typically 
manifests with sharply demarcated chronic erythematous plaques covered by 
silvery white scales, which most commonly appear on the elbows, knees, scalp, 
umbilicus, and lumbar area. Histopathological features of psoriatic skin include: 
epidermal achantosis (thickening of the viable epidermis layers do to an abnormal 
keratinocytes turnover), hyperkeratosis (thickened cornified layer), parakeratosis 
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(retention of nuclei in the stratum corneum) and exaggerated angiogenesis.    
There is also an inflammatory infiltrate within the skin layers consisting of         
T-lymphocytes, dendritic cells (DCs), macrophages, mast cells and neutrophils. 
The latter cells are responsible for the formation of subcorneal micro-abscesses, 
also referred to as Munro‟s microabscesses.  
 
1.3  Triggering factors 
Psoriasis is a chronic autoimmune skin disease, whose multifactorial pathogenesis 
is thought to result from a combination of genetic, environmental and 
immunologic factors (Deng et al. 2016).  
 
1.3.1  Genetic triggers 
The high concordance rates found in twins and families affected by psoriasis 
support the evidence for a strong genetic component in psoriatic disease (Bowcock 
2005). Initial linkage analysis of several affected families allowed the 
identification of at least 12 psoriasis-susceptibility (PSORS) loci (Pasić et al. 
2009). More recently, genome-wide association studies (GWAS) focused on these 
large genome regions unveiled susceptibility genes carrying single nucleotide 
polymorphisms (SNPs). A significant percentage of susceptibility genes is related 
to the immune system, spanning an array of functions that involve antigen 
presentation (HLA-Cw6, ERAP1, ERAP2, MICA), the IL-23 axis (IL12Bp40, 
IL23Ap19, IL23R, JAK2, TYK2), T-cell development and T-cells polarization 
(RUNX1, RUNX3, STAT3, TAGAP, IL4, IL13), innate immunity (CARD14,      
c-REL, TRAF3IP2, DDX58, IFIH1) and negative regulators of immune responses 
(TNIP1, TNFAIP3, NFKBIA, ZC3H12C, IL36RN, SOCS1) (Tsoi et al. 2012).  
 
1.3.2  Environmental triggers  
Genetics is only a part of the pathogenesis. Indeed, without certain environmental 
triggers, epigenetic modification and inflammatory responses, people with high 
genetic susceptibility may still fail to develop psoriasis, even though they are at 
significantly higher risk. Psoriasis is indeed known to be either triggered or 
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exacerbated also by non-specific exogenous factors, such as mild physical trauma 
(tattoos, sunburns, scratching) (Sagi & Trau 2011). Strong evidence also exists for 
psoriasis onset after tonsillar Streptococcus pyogenes infection (Gudjonsson et al. 
2003). The use of various drugs, such as lithium, β-blockers, antimalarial agents, 
non-steroidal anti-inflammatory drugs, and angiotensin-converting enzyme 
inhibitors, has also been associated with onset or worsening of disease in psoriatic 
patients (Basavaraj et al. 2010). In addition, a possible association between 
vaccination and the new onset and/or exacerbation of psoriasis has been reported 
recently (Gunes et al. 2015).  
 
1.3.3  Epigenetics in psoriasis 
Increasing data suggest an emerging role of epigenetics in psoriatic disease as a 
plausible link between environmental exposure and psoriasis development. In this 
context, methylation of genes involved in the modulation of cell proliferation and 
apoptosis, such as SHP-1 and p16 respectively, was found abnormal in patients 
with psoriasis compared to healthy controls (Chen et al. 2008), (Ruchusatsawat et al. 
2006). Abnormal expression of histone acetyltransferases (HATs) and histone 
deacetylases (HDACs) has also been observed in psoriatic skin samples (Tovar-
Castillo et al. 2007). Zhang P and colleagues demonstrated that hypoacetylation of 
histone H4 is observed in peripheral blood of psoriatic patients, and that the 
degree of hypoacetylation of histone H4 inversely correlates to disease severity 
(Zhang et al. 2011). Importantly, emerging evidence has indicated that HDAC 
inhibitors (HDAC-Is) can be used in the treatment of psoriasis (McLaughlin & La 
Thangue 2004). Another epigenetic mechanism found to play a role in the 
pathogenesis of psoriasis is RNA-associated silencing (Sonkoly et al. 2007).  
 
1.4  Pathogenesis 
In the past psoriasis was believed to be a disease primarily caused by intrinsic 
alterations of epidermal keratinocyte proliferation. Around 1980, however, several 
observations supported the central role of immune cells in the pathogenesis of 
psoriasis (Bos et al. 2005). Genetic data on human leukocyte (HLA) associations 
with psoriasis development, as well as data on the presence of oligoclonal T cells 
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in human psoriatic skin, further underline the importance of the immune system in 
psoriasis pathogenesis (Eberle et al. 2016). Loss of tolerance against putative                 
auto-antigens, including keratins, the antimicrobial peptide LL37, heat shock 
proteins and the melanocytic antigen ADAMTSL5-like protein 5 (ADAMTSL5), 
have also been recognized as an important factor contributing to disease 
pathogenesis (Besgen et al. 2010; Arakawa et al. 2015). For many years, psoriasis 
was considered a Th1-type disease in which IFN-γ and TNF were the predominant 
pathogenic driver cytokines. More recently, deregulated axis involving the 
overproduction of IL-23, and the consequent activation of IL-17 producing T cell 
subsets (T17), has instead emerged as the central immune pathway driving 
psoriasis development (Zaba et al. 2009). IL-23 expressed by inflammatory DCs 
drives Th17 development and expansion. In turn, Th17-driven IL-17A and IL-22 
act on keratinocytes to induce CC chemokine 20 (CCL20) and anti-microbial 
peptides production (Wilson et al. 2007) which sustains skin inflammation. This 
inflammatory loop is then amplified by the capability of keratinocyte-derived 
CCL20 to further recruit CCR6-bearing Th17 cells, which, in turn, further activate 
keratinocytes to produce CCL20 in a positive feedback manner (Chiricozzi et al. 
2011). The overproduction of other inflammatory cytokines, such as IL-1, IL-36, 
TNFα and IL-22, is also known to trigger pivotal pathogenic pathways in human 
psoriasis (Johnston et al. 2017; Johnston & Gudjonsson 2014) (Figure 1). 
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From Di Meglio et al, 2014 
 
Figure 1. Psoriasis immunopathogenesis. A pathogenic crosstalk between innate and 
adaptive immune cells sustained by pro-inﬂammatory mediators, underlies the 
deregulated immune response seen in psoriasis. The three main cellular players and their 
products are depicted in this diagram. Keratinocytes (KCs) produce key cytokines, while 
activated DCs present yet undefined antigens and secrete mediators leading to the 
differentiation and activation of IL-17-producing T cells (T, here representing both αβ 
and γδ T cells). T cells, in turn, secrete cytokines that activate KC aberrant differentiation 
program and induce the production of further pro-inﬂammatory mediators, especially 
chemokines (CXCL1, CXCL8) recruiting neutrophils (not shown) or other immune cells 
(CXCL9, CXCL10, CCL20), as well as other antimicrobial peptides (AMPs) (not 
shown). Critical pro-inﬂammatory molecules, effectively targeted by biologic drugs, are 
shown in red. 
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Among the cellular mediators, today there is a widely accepted consensus that 
psoriatic lesions originate as a result of a deregulated crosstalk between 
keratinocytes and resident cutaneous immune cell types belonging to both the 
adaptive and the innate branch of the immune system. However, despite the large 
experimental knowledge already existing on psoriasis pathogenesis, there is still 
an on-going debate on which is/are the immune cell type/s primarily involved in 
disease initiation and progression. What is now emerging is that psoriasis is a 
dynamic disease in which specific cell types can dominate over the others and 
sustain the mounting inflammation during the different phases of disease, 
including disease development, progression and maintenance. As anticipated 
above, the crucial role of DCs (Jariwala 2007) and T17 [including T helper 17 
(Th17) and, to a lower extent,  T cells] (Diani et al. 2015; Papotto et al. 2017) has 
been widely studied in psoriatic patients as well as in preclinical models of 
psoriasis (Cai et al. 2011; C. Wohn et al. 2013). By contrast, the role of myeloid cells 
in diseases pathogenesis (such as neutrophils, monocytes and macrophages), 
which are also known to infiltrate the psoriatic plaques and to display abnormal 
functions in psoriatic patients, is less well characterized (Deng et al. 2016; Coimbra 
et al. 2012; Schön et al. 2017). Focus of this thesis has been to better characterize the 
role of neutrophils in psoriasis pathogenesis. Particular attention has been 
dedicated to better understand the ability of these cells to modulate the IL-23\T17 
axis and  T cells (an innate-like T cell type of IL-17 producing T cells) during 
psoriasis development. 
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1.4.1  IL-23/IL-17A axis 
IL-23 is a heterodimer of a unique IL-23p19 and shared IL-12/23p40 chains 
produced by both resident dermal DCs and inflammatory mDCs, as well as 
macrophages in psoriasis (Zaba et al. 2009). A broad bunch of evidence suggests a 
pathogenic role for IL-23 in psoriasis. Indeed, expression of IL-23p19, IL-23p40 
and IL-23R is increased in psoriasis lesional skin (Tonel et al. 2010), along with an 
increased number of Th17 cells in the dermis (Lowes et al. 2008) and in the blood. 
Moreover intradermal injection of IL-23 in mouse skin resulted in erythema with 
psoriasis-like histological features (Chan et al. 2006). The clinical success of 
biologic drugs targeting IL-12/IL-23p40 confirms the importance of this cytokine 
and its associated pathways, in psoriasis. In fact, IL-23 represents a crucial 
mediator in psoriatic inflammation, driving the development of IL-17 and IL-22 
producing Th17 cells. Importantly, IL-23 along with its receptor and downstream 
transcription factor STAT3, are all genes that are associated with increased 
susceptibility to psoriasis development. Of note, activation of STAT3 and RORγδ, 
another Th17 characterizing transcription factor, is required for IL-17A and IL-
17F expression. Th17, which largely infiltrate psoriatic skin dermis in humans, 
represent an important source of IL-17A, IL-17F, and IL-22 (Ortega et al. 2009; Cai 
et al. 2011). IL-17A and IL-17F share high structural and functional homology and 
primarily activate KCs to produce leukocyte recruiting chemokines, AMPs and 
many inflammatory mediators. IL-17A/F can also mobilize neutrophils, working 
as a link between adaptive and innate immunity (Pelletier et al. 2010), and further 
create a self-sustaining loop through IL-17A induced production of CCL20 by 
KCs. Besides Th17 cells, IL-17A and/or IL-22 are produced by other cell types of 
immune cells identified in psoriatic skin, including innate lymphoid cells (ILCs)3 
and γδ T cells (Chien et al. 2014; Artis & Spits 2015). 
 
1.4.2  γδ T Cells 
γδ T cells account for approximately 3-5% of all lymphoid cells found in the 
secondary lymphoid tissue and the blood whereas they are highly enriched in 
different epithelial tissues, such us the intestinal mucosa, the skin and the 
reproductive tract. These cells represent, therefore, the first line of defence against 
14 
 
pathogens by providing a rapid cytokine response. γδ T cells are the first immune 
cells found in the fetus and provide immunity to new-borns prior to activation of 
the adaptive immune system (Sinkora et al. 2005). While αβ CD4+T cells mostly 
leave the thymus as 'naive' cells that differentiate upon activation in the 
periphery, γδ T lymphocytes are generated in the thymus from CD27+γδ-cell-
committed progenitor, and acquire their effector function during thymic 
development (Muñoz-Ruiz et al. 2017). After functional rearrangement and 
expression of the γ and δ-TCR chains, these cells become reprogrammed 
depending on the TCR signalling strength: strong agonists lead differentiation 
towards an IFN-γ -producing lineage, which can be identified on the basis of the 
expression of the co-stimulatory receptor CD27 (Haas et al. 2009). In contrast low 
TCR signalling leads to the development of IL-17-producing γδ T cells 
expressing RORγδ (Th17-lineage transcription factor) and other surface 
receptors including CD127 (IL7R) and CCR6 (Kisielow et al. 2008).  
Several chemokine receptors, cytokine receptors and pattern recognition receptors 
(PRRs) are expressed by γδ T cells and have been showed to be involved in their 
activation. Production of IL-23, IL-1 and IL-18 by activated DCs and 
macrophages promotes IL-17 production by γδ T cells (Sutton et al. 2009).  
Despite the fact that the activation of γδ T cells relies mainly on innate cytokines, 
it appears to be also regulated and „fine-tuned‟ by various accessory receptors 
such us programmed cell death protein 1 (PD-1), the B and T lymphocyte 
attenuator (BTLA) and the co-stimulatory receptor CD28 (Ribot et al. 2012). 
Mouse skin harbours distinct subsets of γδ T cells which differ according to the 
skin layer. In the epidermis there is a large number of γδ T cells which, do to their 
marked dendritic morphology, have been named dendritic epidermal T cells 
(DECT) (Havran & Jameson 2010). DECT express the canonical Vγ5Vδ1 TCR and 
participate in tissue surveillance and wound healing producing keratinocyte 
growth factors and IFN-γ  (Jameson et al. 2002). In the dermis, the Vγ4+ and Vγ6+ 
T cells are the most represented subsets and are responsible for pathogenic 
inflammatory responses mediated by the production of IL-17 (O‟Brien & Born 
2015). Moreover dermal γδ T cells, but not epidermal γδ T cells, constitutively 
express CCR6 and RORγδ (Cai et al. 2011). Among dermal γδ T cells, resident 
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Vγ6+ cells are long-lived, self-renewing, mostly radio-resistant cells that require a 
source of fetal thymocytes for reconstitution. On the contrary, infiltrating Vγ4+ 
cells migrate from the lymph nodes, are radiosensitive and can be reconstituted 
from bone marrow progenitors (Haas et al. 2012; Roark et al. 2007). Dermal γδ T 
cells have been shown to proliferate and secrete IL-17A, IL-17F and IL-22 when 
cultured in the presence of IL-23 and IL-1β (Cai et al. 2011; Gray et al. 2011). This 
pathogenic signature is critical for triggering the formation of psoriasiform 
plaques in mice, as genetic deletion of these cytokines substantially diminishes the 
disease severity in the imiquimod (IMQ)-induced mouse model of psoriasis (see 
IMQ mouse model below) (Pantelyushin et al. 2012). Furthermore, Cai Y. and 
colleagues showed that skin pathology was diminished in Tcrd
-/-
 (T-cell receptor 
delta chain knock-out) mice treated with IMQ as opposed to Tcra
-/- 
(T-cell 
receptor αβ knock-out) and wild-type mice, suggesting that dermal γδ T cells play 
a major role in driving the IMQ-induced skin inflammation (Cai et al. 2011). Using 
the same animal model, Ramirez-Valle F. and colleagues found an expansion of a 
population of Vγ4+ Vδ4+ T cells that was mostly responsible for IL-17 production.                     
IL-17 producing Vγ4+ Vδ4+ T cells were able to establish long-lived memory in 
the skin, persisting in the dermis for long periods of time after the initial 
stimulation with IMQ. Moreover, experienced Vγ4+ Vδ4+ T cells showed 
enhanced effector functions and mediated and exacerbated secondary 
inflammatory response (Ramírez-Valle et al. 2015; Hartwig et al. 2015).                            
The observation that mice bearing a mutation in the gene encoding Sox13, which 
fail to develop dermal Vγ4+ cells but can generate dermal Vγ6+ cells, had lower 
psoriasis-like dermatitis scores than those of Sox13
+/+
 mice upon IMQ treatment, 
further support the pathologic role of Vγ4+ Vδ4+ T cell population in psoriasis 
(Gray et al. 2013). As discussed above, IL-17 producing dermal γδ T cells have 
been extensively studied in murine models of psoriasis. In contrast to mouse skin, 
γδ T cells are rare in healthy human skin. In fact, approximately 2-9% of all 
dermal cells are γδ T cells (Ebert et al. 2006). Furthermore, the role of these cells in 
human skin, and especially their role in IL-17 signalling, remains poorly 
characterized. There are however few evidence for a novel Vγ9+Vδ2+ T cell 
subset, expressing cutaneous lymphocytes antigen CCR6, which was found to 
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accumulate in psoriatic skin and to be reduced into the circulation of patients.         
This mobilization of CCR6
+Vγ9+Vδ2+ T cells observed in psoriatic patients 
associates with disease severity and is normalized after successful treatment of 
psoriasis (Laggner et al. 2011). 
 
1.4.3  Neutrophils 
Neutrophils are innate immune cells belonging to the family of 
polymorphonuclear leukocytes, that are well recognized as one of the major 
players during acute inflammation (Mantovani et al. 2011). They are typically the 
first leukocytes to be recruited to an inflammatory site and are capable of 
eliminating pathogens by multiple mechanisms. In the circulation, mature 
neutrophils have an average diameter of 7–10μm, their nucleus is segmented and 
their cytoplasm is enriched with granules and secretory vesicles (Mestas & Hughes 
2004). Mature neutrophils develop in the bone marrow from pluripotent 
hematopoietic stem cells (HSC) in a process called “granulopoiesis”. 
Granulopoiesis is strictly dependent on the effects of several colony stimulating 
factors (CSFs), among which granulocyte CSF (G-CSF) is the most important, 
and cytokines, such as IL-6, IL-23 and IL-17 (Bugl et al. 2012). The release of 
neutrophils from the bone marrow to the circulation and peripheral tissue 
contributes to the maintenance of neutrophil homeostasis and, as such, is a tightly 
regulated process. Indeed, in physiological conditions the peripheral neutrophil 
population is maintained within a constant number by balancing the production, 
release and clearance of neutrophils from the circulation. The process is controlled 
by granulocyte colony stimulating factor (G-CSF) (Lieschke et al. 1994), which is 
produced in response to IL-17A synthesized by T cell populations (γδ and natural 
killer T cells) involved in regulating neutrophil homeostasis (Ley et al. 2006). 
Release of IL-17A is, in turn, induced by IL-23 originating from tissue-resident 
macrophages and dendritic cells. During inflammation the number of neutrophils 
in the blood and tissues can increase up to 10-fold. With time the cells die by 
apoptosis and are removed by macrophages and dendritic cells.                                    
This process results in down-regulation of IL-23 synthesis by those cells and thus 
reduces G-CSF release (Stark et al. 2005). 
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Neutrophils were always considered short-lived cells with a half-life in the 
circulation of approximately 1.5 and 8 hours in mice and humans, respectively. 
Recent studies challenged this concept, proposing that under basal conditions the 
average circulatory lifespan of neutrophils is up to 12.5 hours for mouse cells and 
5.4 days for human neutrophils (Pillay et al. 2010). In this context, the notion that 
neutrophil longevity can increase several fold, both in vitro and in vivo, under 
inflammatory conditions has changed the view under which these cells have long 
been considered. Indeed, a longer lifespan may allow neutrophils to carry out 
more complex activities at the inflammatory sites, such as contributing to the 
resolution of inflammation or shaping adaptive immune responses. The classical 
view of neutrophils as “suicide” phagocytic cells capable only to release lytic 
enzymes and to produce reactive oxygen intermediates (ROI) with antimicrobial 
potential (Nathan 2006) has indeed been challenged by the demonstration that these 
cells can actually be induced to express several genes encoding key inflammatory 
mediators, including complement components, Fc receptors, chemokines and 
cytokines (Mantovani et al. 2011; Tecchio & Cassatella 2016).Thus, in response to 
different signals neutrophils express a vast and diverse repertoire of cytokines that 
are crucial to the role of neutrophils in innate and adaptive immune responses and 
to their role in defence and pathology. Accordingly, also the observation that 
neutrophils can infiltrate lymphoid organs, including spleen and lymph nodes, as 
well as the demonstration that neutrophils exhibit complex crosstalk with 
components of the innate and adaptive immune system (including DCs, T and B 
cells) (Scapini & Cassatella 2014) has renewed the interest in these cells within the 
immunology community. Importantly, locally activated neutrophils not only 
amplify the inflammatory process, but, surprisingly, can also actively participate 
in its resolution phase (Jones et al. 2016). In this context, relevant to this thesis, is 
the notion that the inflammatory environment can profoundly shape the functional 
status of neutrophils. Indeed, among the novel discoveries on neutrophil biology, 
concepts such as “neutrophil heterogeneity” and “neutrophil plasticity” have 
started to emerge, implying that, under pathological conditions, neutrophils may 
differentiate into discrete subsets defined by distinct phenotypic and functional 
profiles (Scapini et al. 2016; Silvestre-Roig et al. 2016). 
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Despite the fact that the origin and phenotype of the majority of these neutrophil 
subsets remain unclear, accumulating evidence supports the idea that these 
distinct neutrophil populations may play diverse, and even opposing roles in 
infection, inflammation and cancer immunology (Scapini et al. 2016; Silvestre-Roig 
et al. 2016). For instance, the controversial role of neutrophils in cancer 
pathogenesis is a subject of extensive investigation in the field. Indeed, evidence 
that neutrophils can display both immunosuppressive/pro-tumor and 
immunostimulatory/anti-tumor functions has been reported in both tumour-
bearing mice and in cancer patients (Shaul & Fridlender 2017; Liang & Ferrara 2016). 
In this context, it has been suggested that neutrophils can polarize from an N1 
pro-inflammatory and anti-tumoral phenotype, to an N2 anti-inflammatory and 
pro-tumoral phenotype (Granot & Jablonska 2015). Furthermore, it is now well 
established that myelopoiesis can be profoundly modified during inflammation 
and cancer, releasing altered mature myelocytes and myeloid-derived suppressor 
cells (MDSCs) that exert immunosuppressive and protumoral activity, mainly by 
inhibiting T cell functions (Moses & Brandau 2016; Scapini et al. 2016). Altogether, 
these novel aspects of neutrophil biology have shed a new light not only on the 
potential complex roles that neutrophils play during inflammation and immune 
responses, but also on the pathogenesis of several inflammatory disorders 
including infection, autoimmunity and cancer. In the context of psoriasis, as it will 
be described more in details in the aim of the study and in the discussion of this 
thesis, neutrophil accumulation in the skin is one of the histological features of 
this disease (Perera et al. 2012). In psoriatic skin, neutrophils initially infiltrate into 
the dermis at the early phase and later into the epidermis at the chronic phase. 
However, to date little is known about the pathogenic role of neutrophils in vivo, 
despite the fact that the role of IL-17 in neutrophil-mediated inflammation 
strongly suggests that neutrophils may also participate to psoriasis pathogenesis.  
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1.5  The imiquimod (IMQ) mouse model of psoriasis 
Research on the pathogenesis of psoriasis has been severely hampered by the lack 
of a naturally occurring disorder in laboratory animals that mimics the complex 
phenotype and pathogenesis of the human disease (Bocheńska et al. 2017). 
However, a mouse model of psoriasiform dermatitis caused by the repeated 
topical application of Aldara™ cream [containing the Toll-like receptor 7/8 
(TLR7/8) ligand IMQ (5%)] was described in 2009 (van der Fits et al. 2009). This 
model is currently broadly utilized to elucidate pathogenic mechanisms involved 
in psoriasis development as well as to evaluate possible new therapies for this 
disease. IMQ is a potent immune activator used for topical treatment of infections 
caused by Papilloma virus and other skin-associated abnormalities, including pre-
cancerous skin lesions (Beutner & Ferenczy 1997). IMQ treatment is known to 
exacerbate the disease in patient already affected by psoriasis, also at distant sites, 
suggesting a possible systemic effect of IMQ (Wu et al. 2004). The primary mode 
of action of IMQ in mice is through ligation of TLR7 that activates NF-κB 
signalling in a MyD88-dependent fashion (Hemmi et al. 2002) (Figure 2). 
However, IMQ has been shown to have pro-inflammatory actions independently 
from TLR7 ligation. In fact, IMQ is a ligand for adenosine receptor for which it 
may act as an antagonist leading to inflammation development (Schön et al. 2006). 
Independently of TLR7 and MyD88 signalling, IMQ may also activate the 
inflammasome in keratinocytes via the NALP3 pathway, leading to activation of 
caspase 1 and production of IL-1β and IL-18 (Kanneganti et al. 2006). Repeated 
applications of IMQ-containing cream rapidly induces skin inflammation in mice 
with remarkable pathological and histological resemblance to human psoriasis, 
including the development of skin erythema and scaling, epidermal thickening 
(acanthosis), altered keratinocyte differentiation, neoangiogenesis and skin 
infiltration of immune cells (van der Fits et al. 2009). Interestingly, the involvement 
of a deregulated IL-23/IL-17 axis and the overproduction of other inflammatory 
cytokines, such as IL-1, IL-36 and IL-22, that are known to trigger pivotal 
pathogenic pathways involved in human psoriasis, also appears to be mirrored in 
the IMQ-induced psoriasis (Flutter & Nestle 2013a; Tortola et al. 2012; Rabeony et al. 
2015). The murine cell populations that express high levels of TLR7 include 
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macrophages and DCs. IMQ-induced activation of Myd88 in these cells triggers 
the production of IL-23, which is required for the maximal T cell responses and 
inflammation (Costa et al. 2017; C. Wohn et al. 2013). Dermal γδ T cells are the 
major IL-17-producing cells in the skin in response to IL-23 stimulation, while 
conventional αβ T cells do not contribute to the development of psoriasis lesions 
in this model (Kalyan et al. 2014). Overall these observations indicate that IMQ-
induced psoriasis in mice closely resembles human psoriasis in terms of 
phenotypic skin changes and that lesion development is strictly dependent upon 
the IL-23/IL-17 axis (Cai et al. 2011; van der Fits et al. 2009). 
 
 
      
       From Flutter B and Nestle FO 2013 
    
Figure 2. Mechanisms of action of Aldara
TM
. Aldara
TM
 can activate immune responses 
via a number of different pathways including: (i) TLR7-dependent MyD88 pathway 
activation in immune cells, (ii) NALP3 activation of the inflammasome, by IMQ, (iii) 
antagonism of adenosine receptor signalling, (iv) direct activation of the inflammasome 
or MyD88 pathways through unknown receptors by the vehicle (v), imiquimod- or 
vehicle-driven cell death leading to the release of preformed IL-1α and cell debris. 
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2.  Aim of the study 
 
 
 
Neutrophils are the most abundant leukocytes in humans and play a major role in 
driving immune responses against most type of infections. Recently, it has 
become clear that the functions of neutrophils go far beyond the elimination of 
microorganisms and that these cells may contribute to the pathogenesis of 
numerous chronic inflammatory disorders (Kolaczkowska & Kubes 2013; Mócsai 
2013). In this context, despite the fact that the presence and infiltration of 
neutrophils into the epidermis is one of the hallmark histologic features of 
psoriasis (Perera et al. 2012), the role of these cells in disease pathogenesis remains 
poorly understood. The most credited hypothesis views neutrophils as the 
principal cell mediators in the IL-17-dependent pathophysiology of psoriasis, 
suggesting a pro-inflammatory role of neutrophils in this disease. However, data 
emerging from clinical evidence do not allow drawing definitive conclusions.  
Indeed, while some clinical evidence report that agranulocytosis  can improve the 
clinical outcome in patients with different subtype of psoriasis (Pai et al. 1999; 
Toichi et al. 2000), other clinical trials for therapeutic interventions aimed at 
interfering with neutrophil recruitment or functions into the inflammatory skin 
(e.g. anti-human CXCL8 Abs) were not successful (Bhushan et al. 2002; Schön et al. 
2017). Similar controversial results on the pathogenic role of neutrophils in 
psoriasis also emerge from studies in which preclinical models of this disease 
have been utilized (Schön et al. 2000; Singh et al. 2016; Sumida et al. 2014). 
This being said, to better elucidate the role of neutrophils in psoriasis 
development, I utilized the imiquimod (IMQ)-induced mouse model of psoriasis, 
which consists of the topical administration of Aldara ™ cream [containing the 
(TLR7/8) ligand IMQ (5%)] (Flutter & Nestle 2013b; Hawkes et al. 2016). While the 
crucial role of DCs and T cells (mostly γδ T cells) in the development of IMQ-
induced psoriasis has been elegantly demonstrated (Cai et al. 2011; Pantelyushin et 
al. 2012; Singh et al. 2016; Tortola et al. 2012; C. Wohn et al. 2013; Yoshiki et al. 2014), 
the role of neutrophils in this model remains unclear (Figure 3).  
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Indeed, neutrophil depletion resulted in a reduction of IMQ-induced psoriasis in 
one study (Sumida et al. 2014) or to not affect disease development in another study 
(Singh et al. 2016). Herein, by performing neutrophil depletion or utilizing mice 
carrying impairment in neutrophil functions, including p47phox 
-/- 
mice [lacking a 
cytosolic subunit of the phagocyte nicotinamide dinucleotide phosphate (NADPH) 
oxidase (Jackson et al. 1995)] and Syk
fl/fl
Mrp8-cre
+
 mice [carrying the specific 
deletion of the Syk kinase in neutrophils only (Elliott et al. 2011; Van Ziffle & 
Lowell 2009)], I uncovered a novel potential regulatory role of neutrophils in the 
IMQ-induced psoriasis.   
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From Becher B & Pantelyushin, 2014 
 
Figure 3. Initiation of psoriasis by γδ T cells. Several insults can directly activate DCs 
through pattern recognition receptors (PRRs) or indirectly through keratinocyte stress 
(release of IL-1, TNF-α and IL-36). Stress-sensing DCs can produce IL-23, which 
activates γδ T cells to make TNF-α, IL-17 and IL-22, representing an early event in 
psoriasis that is mediated by the innate immune response. IL-22 induces keratinocyte 
proliferation, and TNF-α and IL-17 activate DCs and keratinocytes, leading to 
upregulation of adhesion molecules by the skin epithelium, angiogenesis and chemokine 
production. IL-17–induced chemokines include CXCL1 and CXCL8 and are responsible 
for the recruitment of neutrophils. IL-17R engagement by keratinocytes also leads to local 
production of CCL20, which attracts more circulating CCR6
+
 γδ T cells. This escalates 
into a self-amplifying inflammatory loop that can also be mediated by the adaptive 
immune system.  
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3.  Materials and Methods 
 
 
 
3.1  Mice  
Syk
fl/fl 
and Syk
fl/fl
Mrp8-cre
+ 
mice, were previously described (Van Ziffle & Lowell 
2009), p47phox
−/−
 mice were a gift from Prof. Romani (University of Perugia) and 
were previously described (Jackson et al. 1995). Tcra
-/-
 mice were a gift from Prof. 
Constantin (University of Verona). C57BL/6 mice were purchased from The 
Jackson Laboratory (Bar Harbor, ME, USA). All mice used in this study were on 
a C57BL/6 background and kept in a specific pathogen-free facility. All mouse 
experiments were carried out in accordance with guidelines prescribed by the 
Ethics Committee for the usage of laboratory animals for research purposes at the 
University of Verona and by the Italian Ministry of Health. 
 
3.2  IMQ-induced psoriasis model 
For induction of psoriasis-like skin inflammation, mice at 8–12 wk of age were 
shaved on the back with an electric clipper 1 d prior to treatment and received a 
daily topical dose of 62,5 mg of commercially available IMQ cream (5%) (Aldara 
Cream™, Meda AB) or control cream (vaseline) on their shaved backs for 3 or 6 
consecutive days as previously described (van der Fits et al. 2009; Costa et al. 2017). 
On the fourth or seventh day, the animals were euthanized (Figure 4). Back skin 
was isolated and half was fixed in 10% formaldehyde for histopathology analysis 
while the other half was finely chopped and stored in RNAlater (Ambion) for 
quantitative real-time PCR (qRT-PCR) or digested, as described below, to achieve 
single-cell suspensions for flow cytometry analysis. 
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3.3  Neutrophil depletion 
Mice were injected intra-peritoneally (i.p.) with 300 μg of rat anti-mouse Ly6G 
Ab (clone 1A8; BioXcell) or isotype control Rat IgG2a (clone 2A3; BioXCell), 
dissolved in 300 μl phosphate-buffered saline (PBS) every other day from day 0 to 
day 6 (Figure 4). 
 
 
 
Figure 4. Neutrophil depletion in the IMQ-induced mouse model of psoriasis. 
 
 
3.4  Cell preparation and flow cytometry 
Skin tissue (2 cm X 2 cm) was cut from dorsal skin of the mouse. After removing 
subcutaneous tissue and collagen intensively with forceps, the skin was cut into 
small pieces and digested with 0,4 mg/ml Liberase TM (Roche Ltd.) and 0,5 
mg/ml DNase I (Sigma) in RPMI 1640 medium (Sigma) for 1 hour. Single cell 
suspension was obtained by shredding with gentle Macs Dissociator (Miltenyi 
Biotec) and filtering with 70 μm and 40 μm cell strainer in series. Lymph nodes 
were mechanically dissociated by two frosted microscope slides and passage 
through a 70 μM cell strainer to yield a single-cell solution. Cells were 
resuspended in phosphate buffered saline containing 2 % (vol/vol) fetal calf 
serum, 2 mM EDTA and maintained at 4°C. For flow cytometry, 1–2×106 cells 
were stained. Non-specific binding was blocked by pre-incubation with 0.5 µg 
anti-CD16/32 (2.4G2, Biolegend) and 100 µg mouse IgG (Sigma). Surface 
staining was performed with the following anti-mouse Abs: Ly6G(1A8), TCRαβ 
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(H57-597), CD62L (MEL-14), CD11b (M1/70), CD45 (30-F11), I-Ab 
(MHCII)(AF6-120.1), CD44 (IM7), TCR γ/δ (GL3) from Biolegends; Ly6C (AL-
21), CD11c (HL3), CD3 (145-2C11) and GR-1 (RB6-8C5), from BD Biosciences. 
After final wash, cells were resuspended in staining/wash buffer containing 1 
mg/ml propidium iodide (PI; Sigma-Aldrich) for viability staining according to 
the manufacturer‟s instructions. For intracellular cytokine staining, the cells were 
activated for 4 hours in phorbol 12-myristate 13-acetate (PMA; 50 ng/ml) and 
ionomycin (750 ng/ml) in the presence of brefeldin A (1 mg/ml). Thereafter, cells 
were surface-stained, washed, and then fixed and permeabilized using the 
eBioscience kit as previously described (Scapini et al. 2011). Intracellular staining 
was performed with anti-mouse IL-17A (TC11-18H10.1; eBioscience) or its 
relevant isotype control mAbs. Sample fluorescence was measured by a seven-
color MACSQuant Analyzer (Miltenyi Biotec), while data analysis was performed 
by using FlowJo software Version 8.8.6 (Tree Star, Ashland, OR, USA). 
 
3.5  Quantitative real-time PCR 
Real-time reverse transcription-PCR was performed, as previously described 
(Tamassia et al. 2014), using total RNA isolated from 30 mg of the skin by RNeasy 
Fibrous Tissue Mini Kit (QIAGEN) and utilizing the following gene-specific 
primer pairs (all purchased from Invitrogen) (Table 1). Data were calculated by 
Q-Gene software (http://www.gene) quantification.de/download.html) and 
expressed as mean normalized expression (MNE) units after RPL32 
normalization. 
 
3.6  Skin histology 
Dorsal skin samples (3 mm) were obtained by a transversal cut of the central skin 
area, fixed in 10% neutral buffered formalin and embedded in paraffin blocks by 
using a Tissue-Tek® Tissue Embedding Console System from Diapath (Bergamo, 
Italy). The paraffin blocks were cut into 3 µm thick cross-section and stained with 
hematoxylin and eosin following the standard procedure (immersion in Mayer‟s 
hematoxylin: 2 minutes; immersion in eosin: 3 min) by using a Leica 
Microsystem Autostainer XL ST5010 (Milano, Italy). Epidermal thickness was 
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determined by measuring the average interfollicular distance under the 
microscope in a blinded manner. Pictures were taken using Leica DFC 300FX 
Digital Color Camera on a Leica DM 6000 B microscope at a 100x magnification.  
 
3.7  Isolation of peritoneal neutrophils 
Peritoneal exudates were recovered 16 hours after i.p. injection of Bio-Gel® P 
Polyacrylamide Beads (Bio Rad). After a passage through a 70 μM cell strainer, 
cell suspensions were incubated with different mAbs as described in the flow 
cytometry section. CD11b
+
Ly6G
+ 
neutrophils were sorted using a FACS AriaTM 
II flow cytometer (Becton Dickinson) (> 99.0 % purity). Alternatively, 
neutrophils were purified using EasySep™ Mouse Neutrophil Enrichment Kit 
according to the manifacturer‟s instructions (>95% purity). Purified cells were 
suspended at proper concentration depending on the assay in RPMI 1640 medium 
supplemented with 10 % FBS, 1 % ultraglutammine and 1 % 
penicillin/streptomycin (BioWhittaker-Lonza), added to 96-well plates and 
cultured at 37˚C, 5 % CO2.    
 
3.8  Proliferation and IL-17A production by γδ T cells 
γδ T cells were isolated from single-cell suspensions of mouse spleen and lymph 
nodes from wild-type or Tcra
-/-
 mice, using the TCRγ/δ+ T Cell Isolation Kit 
(Miltenyi Biotec) (> 85.5 % purity). Proliferation assay was performed in 96-well 
plates pre-coated (for 1 hour at 37˚C) with 10 µg ml-1 anti-CD3 mAbs [(G23-8, 
eBioscience). 1 x 10
5
 γδ T cells /well and 2 µg/ml anti-CD28 mAbs (B122, 
eBioscience) were then added to the plates (at 37˚C, 5 % CO2), in the presence of 
10 ng/mL IL-1β (eBioscience) plus 100 ng/mL IL-23 (eBioscience). After 24 
hours purified peritoneal neutrophils were added to the culture at the appropriate 
ratio. Following a 72 hour-incubation BrdU was added to the co-cultures for 
additional 4 hours; supernatants were then harvested for measurement of IL- 17A 
by using a specific ELISA kit (R&D Systems) while proliferation was determined 
by BrDU incorporation by ELISA (Cell proliferation ELISA, Roche), following 
the manufacturer‟s protocol. γδ T cell inhibition of proliferation is expressed as 
percentage of decrease of the absorbance value (at 450 nm: revealing the amount 
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of BrdU incorporated in proliferating γδ T cells) of each experimental conditions 
over the absorbance value of anti-CD3/CD28-stimulated γδ T cells. 
 
3.9  Quantification of reactive oxygen species  
Oxidative stress detection was performed using the cellROX® Deep Red Flow 
Cytometry Assay Kit (Life Technology). 96-well plates were pre-coated (for 1 
hour at 37˚C) with 10 µg ml-1 anti-CD3 mAbs [(G23-8, eBioscience). 1 x 105 γδ T 
cells/well and 2 µg/ml anti-CD28 mAbs (B122, eBioscience) were added  into the 
plates (at 37˚C, 5 % CO2), in the presence of 10 ng/mL IL-1β (eBioscience) plus 
100 ng/mL IL-23 (eBioscience). The day after purified peritoneal neutrophils 
were added to the culture at 1:1 γδ T cells-to-neutrophils ratio for 1,5 hours. Then 
cells were stained with the CellROX
®
 Deep Red reagent for additional 1.5 hours. 
Sample fluorescence was measured by a seven-colour MACSQuant Analyzer 
(Miltenyi Biotec), while data analysis was performed by using FlowJo software 
Version 8.8.6 (Tree Star, Ashland, OR, USA). 
 
3.10  Statistical analysis 
Data were expressed as the mean ± SD and analysed using GraphPad Prism 
Version 5 software (GraphPad Software, Inc.). The comparison of variables was 
performed using two-tailed Student t- test (for comparison between two groups) 
or a 1-way ANOVA with Bonferroni‟s post test (used for multiple comparisons), 
Dunnett‟s post-test (when multiple comparisons to control group were made).      
P-values of less than 0.05 were considered significant and symbols indicate 
significant increases: *
/#
, P <0.05; **
/##
, P ≤ 0.01; ***/###, P ≤ 0.001; ****/####, P ≤ 
0.0001. Graphs were elaborated using GraphPad Prism Version 5 software 
(GraphPad Software, Inc.). 
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Table 1. List of primer sequences used for RT-PCR 
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4.  Results 
 
 
 
Neutrophil depletion reduces the progression, but not the initiation, of skin 
inflammation and epidermal thickening in the IMQ-induced psoriasis.       
To investigate the specific contribution of neutrophils to the development of IMQ-
induced psoriasis, we performed neutrophil depletion by injecting anti-Ly6G 
(clone 1A8) Ab, or isotype control Ab, in mice treated with IMQ (or vaseline 
control cream), for 3 or 6 consecutive days as originally described by Van der Fits 
et al. (van der Fits et al. 2009). First, we confirmed that the anti-Ly6G-treatment 
successfully depleted neutrophils in lymph nodes and the skin of either vaseline or 
IMQ-treated mice after both 3 and 6 days of treatment (Figure 5).  
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Figure 5. anti-Ly6G antibody (αLy6G) efficiently depletes neutrophil infiltration in 
the lymph nodes and the skin of IMQ-treated mice. Dorsal skin of mice was topically 
treated with IMQ containing-cream (Aldara
®
) or vaseline, utilized as control cream, for 3 
or 6 consecutive days. To deplete neutrophils, mice were injected i.p. with anti-Ly6G 
antibody (αLy6G) or the isotype control (isotype Ab). (A) Draining lymph nodes were 
collected and analysed by flow cytometry. The total number of neutrophils 
(CD11b
+
Ly6C
int 
GR-1
high 
Ly6G
high
) is reported. (B) Total skin (2x2 cm) was digested and 
analysed by flow cytometry. The total number of neutrophils (CD11b
+
Ly6C
int 
GR-1
high 
Ly6G
high
) is reported. (C) Representative FACS plots showing the frequencies of 
CD11b
+
Ly6C
int 
GR-1
high 
Ly6G
high
 neutrophils in the lymph nodes of αLy6G- or isotype 
Ab- treated mice after treatment with IMQ, or vaseline, for 3 or 6 consecutive days. Data 
are pooled from 2 separate time course experiments and are expressed as means ± SD (n 
= 5 mice per time point). Statistical differences of IMQ-treated vs. vaseline-treated mice 
(#) and IMQ-treated vs. IMQ-treated mice following neutrophil depletion (*) are 
reported. #P ≤ 0.05; **P ≤ 0.01; ###/***P ≤ 0.001; ####/**** P ≤ 0.0001 by 1-way 
ANOVA with Bonferroni‟s post-test. 
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Interestingly, neutrophil depletion did not significantly affect epidermal 
thickening up to 3 days of IMQ treatment (Figure 6A). However, differently from 
what previously published (Singh et al. 2016; Sumida et al. 2014), we observed an 
unexpected significant increase of epidermal thickening in neutrophil-depleted 
mice, as compared to control mice, upon 6 days of IMQ treatment (Figure 6A, B). 
Consistently, the expression of skin-associated psoriatic genes by qRT-PCR, such 
as Lipocalin-2 (Lcn2) and S100 calcium binding protein A7/psoriasin (S100A7) 
was significantly higher in IMQ-treated mice receiving anti-Ly6G (clone 1A8) 
Ab, as compared to control isotype-treated mice (Figure 7). Strikingly, we also 
observed that, upon IMQ treatment, mice receiving anti-Ly6G Ab manifested a 
significantly increased expression of cytokines implicated in the IL-23/T17 axis, 
including IL-23, IL-22, IL-17, as compared to control isotype-treated mice 
(Figure 7). Neutrophil depletion, instead, did not significantly affect the 
expression of other inflammatory cytokines induced by IMQ treatment, such as 
IL-1, IL-36α and IL-1 (Figure 7).   
Overall, these data suggest a novel potential role for neutrophils as negative 
modulators of disease progression and of the IL-23/T17 axis in the IMQ-induced 
psoriasis. 
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Figure 6. Increased epidermal thickening in neutrophil-depleted mice in response to 
IMQ treatment. Dorsal skin of mice was topically treated with vaseline or IMQ-
containing cream (Aldara
®
) for 3 or 6 consecutive days. Mice were injected with the 
depleting antibody αLy6G or isotype control antibody (isotype Ab). (A) The height of 
epidermal hyperplasia was measured in interfollicular epidermis on H&E-stained slides 
by light microscopic evaluation. Data are pooled from 3 separate time course experiments 
and are expressed as means ± SD. Statistical differences of IMQ-treated vs. vaseline-
treated mice (#) and IMQ-treated vs. IMQ-treated mice following neutrophil depletion (*) 
are reported. **P ≤ 0.01; ####P ≤ 0.0001 by 1-way ANOVA with Bonferroni‟s post-test. 
(B) Representative H&E-staining of dorsal skin from mice injected with isotype Ab or 
αLy6G treated with vaseline or IMQ for 6 days. Original magnification, X100; original 
scale bars 40μm.  
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Figure 7. Gene-expression analysis of inflammatory molecules in the skin of IMQ-
treated control or neutrophil-depleted mice. The dorsal skin of mice was topically 
treated with IMQ-containing cream (Aldara
®
) or vaseline for 6 consecutive days. Mice 
were injected with the depleting antibody αLy6G or isotype control antibody (isotype 
Ab). Total skin RNA was extracted and reverse transcribed. mRNA expression of the 
indicated genes for IMQ-treated control or neutrophil-depleted mice is displayed as fold 
change of MNE units (after RPL32 normalisation) over vaseline-treated control. Data are 
pooled from 2 separate experiments and are expressed as means ± SD (n = 8-12 mice). 
Statistical differences of IMQ-treated vs. IMQ-treated mice following neutrophil 
depletion (*) are reported. ***P ≤ 0.001; ****P ≤ 0.0001 by  t test. 
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Neutrophil depletion increases the expansion and infiltration of γδ T cells in 
lymph nodes and skin of IMQ-treated mice.  
We then performed a careful characterization of the CD45
+
 cells infiltrating the 
draining lymph nodes and the skin of IMQ-treated mice receiving anti-Ly6G Ab 
or control isotype Ab by flow cytometry, utilizing the gating strategies previously 
described (Costa et al. 2017). Interestingly, after 6 days of IMQ treatment, we 
found strongly increased infiltration of γδ T cells in the draining lymph nodes of 
neutrophil-depleted mice, γδ T cells being the main pathological T cells in this 
mouse model of psoriasis (Cai et al. 2011; Pantelyushin et al. 2012) (Figure 8A, B-
left panel). Besides the total number, also the number of CD44
high
CD62L
low
 
effector γδ T cells and of IL-17-producing γδ T cells were significantly increased, 
indicating that not only the infiltration but also the activation of these cells was 
profoundly affected by neutrophil depletion (Figure 8B-right panel, C, D). No 
significant differences in the infiltration of αβ T cells (Figure 8E), 
monocytes/macrophages (Figure 8F) and DCs (Figure 8G) were instead found in 
the draining lymph nodes of anti-Ly6G-treated, as compared to control isotype-
treated mice. Notably, a strong expansion of dermal γδ TCRlow T cells was evident 
also in the skin of anti-Ly6G-treated, as compared to control isotype-treated mice 
after 6 days of IMQ treatment (Figure 9A, B). No significant differences in the 
infiltration of monocytes/macrophages (Figure 9C), DCs (Figure 9D) and 
TCR
+αβ T cells (E) were instead found in the skin of anti-Ly6G-treated, as 
compared to control isotype-treated mice. It is worth to point out that, under our 
experimental conditions, γδ T cells and neutrophils infiltrated the lymph nodes 
and the skin of IMQ-treated mice with similar kinetics, being the infiltration of 
both cell types much more consistent after 6 rather than 3 days of IMQ-treatment 
(Figure 5A, B and figure 10A, B).  
Overall, these data point out at neutrophils as potential negative regulators of the 
infiltration and expansion of γδ T cells in the lymph nodes and skin of IMQ-
treated mice.  
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Figure 8. Infiltration of inflammatory cells in the draining lymph nodes of IMQ-
treated control or neutrophil-depleted mice. The dorsal skin of mice was topically 
treated with IMQ-containing cream (Aldara
®
) or vaseline, utilized as control cream, for 6 
consecutive days. Mice were injected with the depleting antibody αLy6G or isotype 
control antibody (isotype Ab). Draining lymph nodes were collected and analysed by 
flow cytometry. Panels report: the total number of neutrophils (Ly6C
int
 Ly6G
high 
GR-1
high
) 
(A), the number of total (left panel) and effector (CD44
high
CD62L
low
, right panel)
 γδ TCR+ 
cells (B), the number of IL-17A-producing γδ TCR+ cells (C), the frequencies of IL-17A-
producing γδ TCR+ cells (representative FACS plots) (D), the number of αβ TCR+ T cells 
(E), the number of monocytes/Mϕ (CD11bhighLy6G-CD11clow/-MHCIIlow/- cells plus 
CD11b
high
Ly6G
-
CD11c
low
/
-
MHCII
high
 cells) (F), and the number of DCs 
(CD11c
+/high
MHCII
high
) (G). Data are pooled from 3 separate experiments and are 
expressed as means ± SD (n = 14-15 mice). Statistical differences of IMQ-treated vs. 
vaseline-treated mice (#) and IMQ-treated vs. IMQ-treated mice following neutrophil 
depletion (*) are reported. #/*P ≤ 0.05; ##P ≤ 0.01; ###/***P ≤ 0.001 by 1-way ANOVA 
with Bonferroni‟s post-test. 
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Figure 9. The infiltration of γδ T cells is increased in the skin of neutrophil-depleted 
mice treated with IMQ. The dorsal skin of mice was topically treated with IMQ-
containing cream (Aldara
®
) or vaseline for 6 consecutive days. Mice were injected with 
the depleting antibody αLy6G or the isotype control antibody (isotype Ab). Total skin 
(2x2 cm) was digested and analysed by flow cytometry. Panels report: the total number of 
neutrophils (Ly6C
int
 GR-1
high 
Ly6G
high
) (A), dermal γδ TCRlow T cells (B), monocytes/Mϕ 
(CD11b
high
Ly6G
-
CD11c
low/-
MHCII
low/-
 cells plus CD11b
high
Ly6G
-
CD11c
low
/
-
MHCII
high
 
cells) (C), DCs (CD11c
+/high
MHCII
high
) (D) and αβ TCR+ T cells (E). Data are pooled 
from 2 separate experiments and are expressed as means ± SD (n = 8-10 mice). Statistical 
differences of IMQ-treated vs. vaseline-treated mice (#) and IMQ-treated vs. IMQ-treated 
mice following neutrophil depletion (*) are reported. #/*P ≤ 0.05; ##P ≤ 0.01; ###P ≤ 
0.001; ####P ≤ 0.0001 by 1-way ANOVA with Bonferroni‟s post-test. 
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Figure 10. Skin infiltration of γδ T cells in the lymph nodes and skin of mice treated 
with IMQ for 3 and 6 days. Dorsal skin of mice was topically treated with vaseline or 
IMQ-containing cream (Aldara
®
) for 3 or 6 consecutive days. (A) Draining lymph nodes 
were collected and analysed by flow cytometry. The total number of γδ TCR+ cells is 
reported. (B) Total skin (2x2 cm) was digested and analysed by flow cytometry. The total 
number of dermal γδ TCRlow T cells is reported. Data are pooled from 2 separate time 
course experiments and are expressed as means ± SD (n = 5 mice). Statistical differences 
of IMQ-treated vs. vaseline-treated mice (#) and IMQ-treated mice after 3 days vs. IMQ-
treated mice after 6 days (*) are reported. #/*P ≤ 0.05; **P ≤ 0.01; #### P ≤ 0.0001 by 1-
way ANOVA with Bonferroni‟s post-test. 
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Neutrophils inhibit the proliferation and the production of IL-17 by γδ T 
cells via cell contact-dependent reactive oxygen species (ROS) production.  
Previous findings have highlighted the capacity of neutrophils to both positively 
and negatively modulate the effector functions of γδ T cells (Davey et al. 2014; 
Kalyan et al. 2014a; Sabbione, María L. Gabelloni, et al. 2014; Hassane et al. 2017). 
Therefore we investigated the effect of neutrophils on the proliferation and the 
production of IL-17 by γδ T cells stimulated with anti-CD3 Abs plus anti-CD28 
Abs in the presence of 100 ng/mL IL-23 and 10 ng/mL IL-1β, as previously 
described (Cai et al. 2011; Costa et al. 2017). As shown in Figure 11A, B, 
neutrophils inhibited both the proliferation and the production of IL-17 by 
activated γδ T cells. Given that the degree of this inhibitory effect was dependent 
on the ratio with T cells (Figure 11A, B), in all subsequent experiments we used 
the 5/1 neutrophil/T cell ratio, condition in which we obtained a strong and 
reproducible inhibition of γδ T cell functions by neutrophils. Similarly, to what 
published by Sabbione et al. (Sabbione, María L. Gabelloni, et al. 2014) with human 
neutrophils, we found that the addition of either catalase (a H2O2 scavenger) or of 
diphenyleneiodonium (DPI, a NADPH oxidase inhibitor) strongly reverted the 
immunosuppressive functions of mouse neutrophils on γδ T cells (Figure 11C, 
D), while other inhibitors, including pentoxyfilline (PTX, a degranulation 
inhibitor) or L-arginine [an arginase-1 (ARG1) inhibitor] were not effective 
(Figure 11C, D). Taken together, these data suggested that the inhibitory effects 
of neutrophils on γδ T cell functions in the IMQ-induced mouse model of 
psoriasis involves the production of ROS. In line with these observations, 
neutrophils isolated from p47
phox-/- 
mice were unable to effectively inhibit γδ T 
cells (Figure 12A). Furthermore, by performing a flow cytometric measurement 
of ROS production, we also observed that the production of ROS by wild-type 
(WT) neutrophils, but not by p47
phox-/- 
neutrophils, was strongly enhanced by the 
presence of γδ T cells in the culture (Figure 12B). Finally, in line with the fact 
that the inhibitory functions of different immunosuppressive neutrophil 
populations have been shown to occur through direct cell contact-dependent 
mechanisms (Choi et al. 2012; Marini et al. 2017; Pillay et al. 2012; Schmielau & Finn 
2001), we found that the capacity of neutrophils to inhibit  T cell proliferation 
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was significantly lower if neutrophils were separated from T cells by the use of 
transwells (Figure 12C).   
Overall, the results obtained so far show that neutrophils inhibit γδ T cell 
functions via a cell contact-dependent triggered ROS production. 
 
 
 
 
Figure 11. Neutrophils inhibit the proliferation and IL-17 production by γδ T cells 
via reactive oxygen species (ROS) production. (A, B) γδ T cells were stimulated with 
CD3/CD28, 100 ng/ml IL-23 plus 10 ng/ml IL-1β and cultured for 72h in the presence or 
absence of neutrophils at different ratios. (C, D) γδ T cells were stimulated with 
CD3/CD28, 100 ng/ml IL-23 plus 10 ng/ml IL-1β and cultured for 72h with neutrophils 
added at a 1 to 5 γδ T to neutrophil cell ratio, with or without inhibitors: catalase (1000 
U/ml), diphenyleneiodonium (DPI) (0,1 μM), L-arginine (200 μg/ml-1), pentoxifillin 
(PTX) (0,5 μM). The percentages of inhibition of proliferation, as measured by BrdU 
incorporation (A, C), or IL-17A production (B, D) by γδ T cells, are reported. Graph 
values indicate means ± SD from 2 to 3 independent experiments. Statistical differences 
of the effect of neutrophils in the presence or absence of inhibitors are reported. *P ≤ 
0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001 by 1-way ANOVA with Dunnett‟s post-
test. 
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Figure 12. Neutrophil-mediated inhibition of γδ T cell proliferation requires 
(NADPH) oxidase-dependent ROS production and direct cell-to-cell contacts. γδ T 
cells were stimulated with CD3/CD28, 100 ng/ml IL-23 plus 10 ng/ml IL-1β and cultured 
with neutrophils, from wild-type (WT) or p47
phox-/- 
mice. Neutrophils were added at a 1 to 
5 γδ T to neutrophil cell ratio for 72 hours (A, C) or at a 1 to 1 γδ T to neutrophil cell 
ratio for 3 hours (B). (A) Percentages of inhibition of γδ T cell proliferation by 
neutrophils from WT or p47
phox-/- 
mice as measured by BrdU incorporation.                    
(B) Representative FACS histogram plots depicting the Cell-RoX MFI of CD11b
+
Ly6G
+
 
neutrophils from WT or p47
phox-/- 
mice in the presence or absence of γδ T cells, as 
evaluated by FACS analysis. (C) Stimulated γδ T cells were cultured with neutrophils 
under direct contact or transwell conditions. The graph shows the percentages of 
inhibition of γδ T cell proliferation, as measured by BrdU incorporation. Graph values 
indicate means ± SD from 2 independent experiments. *P ≤ 0.05; **P ≤ 0.01, by  t test. 
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Syk signalling modulates the capacity of neutrophils to inhibit γδ T cell 
functions and disease progression in the IMQ-mouse model of psoriasis. 
Spleen tyrosine kinase (Syk), a member of non-receptor tyrosine kinases, 
transmits signals in neutrophils from a variety of immunoreceptors, including Fcγ 
receptors (FcγRs) (Futosi et al. 2013), adhesion molecules, such as β2 integrins 
(Mócsai et al. 2002) and P-Selectin glycoprotein ligand 1 (PSGL-1) (Stadtmann et al. 
2013). As a consequence, Syk 
-/-
 neutrophils display impaired effector functions, 
including  the production of ROS  and the release of granule contents, in response 
to several inflammatory stimuli (Futosi et al. 2013).   
Syk-based signalling in neutrophils alone was previously shown to be critical for 
appropriate host defence to Staphylococcus aureus (Van Ziffle & Lowell 2009) or 
the development of inflammatory arthritis (Elliott et al. 2011), suggesting the 
relevance of this signalling pathway in neutrophils during immune responses. 
Therefore, we decided to utilize mice carrying the specific deletion of Syk in 
neutrophils [Syk
fl/fl
Mrp8-cre
+ 
mice (Elliott et al. 2011; Van Ziffle & Lowell 2009)], 
available in our laboratory, as an experimental model to test whether the specific 
impairment of this signalling pathway in neutrophils was sufficient to affect the 
interactions of these cells with  T cells and IMQ-induced psoriasis. 
Consistently, Syk 
-/-
 neutrophils failed to produce ROS and to inhibit γδ T cells 
proliferation under our experimental conditions in vitro (Figure 13A, B). These 
data validated therefore Syk as crucial signalling molecule involved in the 
modulation of neutrophil capability to inhibit γδ T cell functions via a contact-
dependent ROS production.  
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Figure 13. ROS-mediated inhibition of γδ T cell proliferation by neutrophils 
requires the activation of Syk-dependent signalling pathways. γδ T cells were 
stimulated with CD3/CD28, 100 ng/ml IL-23 plus 10 ng/ml IL-1β and cultured with 
neutrophils from Syk
fl/fl
 or Syk
fl/fl
Mrp8-cre
+
 mice at a 1 to 1 γδ T to neutrophil cell ratio for 
3 hours (A) or at a 1 to 5 γδ T to neutrophil cell ratio for 72h (B). (A) Representative 
FACS histogram plots depicting the CellROX MFI of CD11b
+
Ly6G
+
 neutrophils from 
Syk
fl/fl
 or Syk
fl/fl
Mrp8-cre
+
 mice in the presence or absence of γδ T cells , as evaluated by 
FACS analysis. (B) Percentages of inhibition of γδ T cell proliferation by neutrophils 
from Syk
fl/fl
 or Syk
fl/fl
Mrp8-cre
+
 mice, as measured by BrdU incorporation. Graph values 
indicate means ± SD from 2 independent experiments. *P ≤ 0.05 by  t test. 
 
 
 As far as IMQ-induced psoriasis experiments, we initially found that Syk
fl/fl
Mrp8-
cre
+ 
mice did not manifest, as compared to control Syk
fl/fl
 mice, a significant 
increase of epidermal thickness, after 6 days of IMQ-treatment (Figure 14A).  
Interestingly, however, similarly to neutrophil-depleted mice, Syk
fl/fl
Mrp8-cre
+
 
mice manifested, as compared to control Syk
fl/fl
 mice, an enhanced expression of 
skin-associated psoriatic genes, such as S100A7 and Lcn2, as well as a specific 
increase in the expression of cytokines implicated in the IL-23/T17 axis, including 
IL-23, IL-22, IL-17, after 6 days of IMQ treatment (Figure 14B). Furthermore, 
also the number of total and activated γδ T cells producing IL-17, but not of other 
cell types, was increased in the draining lymph nodes of Syk
fl/fl
Mrp8-cre
+
 mice, as 
compared to control mice, after 6 days of IMQ treatment (Figure 15). On a 
similar fashion, the number of dermal γδ T cells infiltrating into the skin of IMQ-
treated Syk
fl/fl
Mrp8-cre
+
 mice was significantly increased as compared to IMQ-
treated control mice (Figure 16A, B). It is noteworthy to remark that, in line with 
the fact that Syk is not directly involved in controlling neutrophil migration to the 
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inflammatory sites (Mócsai et al. 2002), we did not notice any significant difference 
in the capacity of Syk 
-/-
 neutrophils to infiltrate the lymph nodes and the skin in 
response to IMQ treatment (Figure 15A and Figure 16A). This observation, 
together with the fact that the deletion efficiency of the Mrp8-cre is only about 80-
90 % (Elliott et al. 2011), meaning that about 10 to 20% of circulating neutrophils 
are Syk
+/+
, can potentially explain why the specific neutrophil impairment present 
in Syk
fl/fl
Mrp8-cre
+
 mice was sufficient to reproduce only the increase in skin 
inflammation and γδ T cell infiltration, but not the overall increase in epidermal 
thickening observed in mice with a complete neutrophil depletion. Anyhow, data 
clearly suggests that Syk-dependent signalling pathways controlling neutrophil 
effector functions, but not neutrophil migration, are required for the neutrophil-
mediated inhibition of γδ T functions in vitro and in vivo.  
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Figure 14. Epidermal thickening and gene-expression analysis of inflammatory 
molecules in the skin of IMQ-treated Syk
fl/fl
 and Syk
fl/fl
Mrp8-cre
+
 mice. The dorsal 
skin of control Syk
fl/fl
 and Syk
fl/fl
Mrp8-cre
+
 mice was topically treated with IMQ-
containing cream (Aldara
®
) or vaseline for 6 consecutive days. (A) The height of 
epidermal hyperplasia (epidermal thickening) was measured in interfollicular epidermis 
on H&E-stained slides by light microscopic evaluation. (B) Total skin RNA was 
extracted and reverse transcribed. mRNA expression of the indicated genes for IMQ-
treated Syk
fl/fl
 and Syk
fl/fl
Mrp8-cre
+
 mice is displayed as fold change of MNE units (after 
RPL32 normalisation) over vaseline-treated controls. Data are pooled from 2 separate 
experiments and are expressed as means ± SD (n = 11 mice). Statistical differences of 
IMQ-treated Syk
fl/fl
 or Syk
fl/fl
Mrp8-cre
+
 mice vs. vaseline-treated mice (#) and IMQ-
treated Syk
fl/fl
 vs. IMQ-treated Syk
fl/fl
Mrp8-cre
+
 mice (*) are reported. ####P ≤ 0.0001 by 
1-way ANOVA with Bonferroni‟s post-test. *P ≤ 0.05; ***P ≤ 0.001 by  t test. 
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Figure 15. Infiltration of inflammatory cells in the draining lymph nodes of IMQ-
treated Syk
fl/fl
 and Syk
fl/fl
Mrp8-cre
+
 mice. The dorsal skin of control Syk
fl/fl
 and 
Syk
fl/fl
Mrp8-cre
+
 mice was topically treated with IMQ-containing cream (Aldara
®
) or 
vaseline for 6 consecutive days. Draining lymph nodes were collected and analysed by 
flow cytometry. Panels report: the number of neutrophils (Ly6C
int
 GR-1
high
 Ly6G
high
) (A), 
the number of total (B) and effector (CD44
high 
CD62L
low
)
 γδ TCR+ cells (C), the number 
of IL-17A-producing γδ TCR+ cells (D), the number of αβ TCR+ T cells (E), the number 
of monocytes/Mϕ (CD11bhighLy6G-CD11clow/-MHCIIlow/- cells plus CD11bhighLy6G-
CD11c
low
/
-
MHCII
high
 cells (F), and the number of DCs (CD11c
+/high
MHCII
high
) (G). Data 
are pooled from 2 separate experiments and are expressed as means ± SD (n = 11 mice). 
Statistical differences of IMQ-treated Syk
fl/fl
 or Syk
fl/fl
Mrp8-cre
+
 vs. vaseline-treated mice 
(#) and IMQ-treated Syk
fl/fl
 vs. IMQ-treated Syk
fl/fl
Mrp8-cre
+
 mice (*) are reported. #/*P ≤ 
0.05; ##/**P ≤ 0.01; ###P ≤ 0.001; #### P ≤ 0.0001 by 1-way ANOVA with 
Bonferroni‟s post-test. 
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Figure 16. The infiltration of γδ T cells is increased in the skin of IMQ-treated 
Syk
fl/fl
Mrp8-cre
+
 mice. The dorsal skin of control Syk
fl/fl
 and Syk
fl/fl
Mrp8-cre
+
 mice was 
topically treated with IMQ-containing cream (Aldara
®
) or vaseline for 6 consecutive 
days. Total skin (2x2 cm) was digested and analysed by flow cytometry. Panels report: 
the total number of neutrophils (Ly6C
int
 GR-1
high 
Ly6G
high
) (A), dermal γδ TCRlow T cells 
(B). Data are pooled from 2 separated experiments and are expressed as means ± SD (n = 
6 mice). Statistical differences of IMQ-treated Syk
fl/fl
 or Syk
fl/fl
Mrp8-cre
+
 vs. vaseline-
treated mice (#) and IMQ-treated Syk
fl/fl
 vs. IMQ-treated Syk
fl/fl
Mrp8-cre
+
 mice (*) are 
reported. ##/**P ≤ 0.01; ####P ≤ 0.0001 by 1-way ANOVA with Bonferroni‟s post-test. 
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5.  Discussion 
 
 
 
Neutrophil accumulation in the skin is one of the histological features that 
characterize psoriasis (Boehncke & Schön 2015; Deng et al. 2016). However, the role 
of neutrophils in psoriasis development remains poorly understood. In this study, 
by utilizing the mouse model of IMQ-induced psoriasis, I uncover a novel role of 
neutrophils as negative regulators of disease propagation and exacerbation.          
In fact, neutrophil depletion resulted in an increased epidermal thickening 
accompanied by an increased inflammatory cell infiltration and cytokine/psoriatic 
gene expression. In particular, neutrophil depletion resulted in a profound 
exacerbation of the inflammation associated to the IL-23/T17 pathway. 
Interestingly, such an effect seemed to be mediated by the ability of neutrophils to 
inhibit, via NADPH oxidase-dependent ROS production, the proliferation and the 
production of IL-17 by γδ T cells, key effector components of psoriatic 
inflammation in this model. Finally, we demonstrated, for the first time, that Syk 
function as crucial signalling molecule mediating this inhibitory crosstalk between 
neutrophils and γδ T cells (Figure 17). Aim of future research is to identify the 
specific molecule/s involved in these cell-to-cell contact interactions between 
neutrophils and γδ T cells that is/are responsible of triggering Syk-dependent 
inhibitory functions in neutrophils. 
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Figure 17. The ability of neutrophils to inhibit the proliferation and IL-17 production by 
γδ T cells occurs via cell-contact and NADPH oxidase-dependent ROS production.      
We also propose Syk as important molecules involved in the modulation of this inhibitory 
pathway. 
 
 
Neutrophils, due to their ability to both promote and inhibit inflammatory and 
immune responses, seem to play a rather complex role in several inflammatory 
diseases (Scapini & Cassatella 2014; Scapini et al. 2016; Silvestre-Roig et al. 2016; 
Soehnlein et al. 2017). As far as psoriasis, the current hypothesis is that neutrophils 
play a pro-inflammatory role in disease pathogenesis (Schön et al. 2017). This 
assumption is mostly based on the fact that these cells are generally linked to the 
IL-23/T17-related inflammatory axis and that they have been proposed to sustain 
skin inflammation for example by producing NETs (Lin et al. 2011; Zabieglo et al. 
2015) and other inflammatory cytokines [including IL-17 and IL-22 (Dyring-
Andersen et al. 2017)] or by activating IL-36 family cytokines via the release of 
proteases (Henry et al. 2016). However, to date, compelling evidence of this 
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pathogenic role of neutrophils in psoriasis does not exist. For instance, neutrophils 
have been also proposed to play a regulatory role in psoriatic inflammation via the 
release of elastase and the consequent activation of the anti-inflammatory 
cytokine IL-36 receptor antagonist (Macleod et al. 2016), a negative modulator of 
psoriasis development (Macleod et al. 2016). Only few studies have actually 
attempted to clarify the pathogenic role of neutrophils in disease pathogenesis by 
utilizing different types of preclinical models (Schön et al. 2000; Singh et al. 2016; 
Sumida et al. 2014). In one study performed on flaky skin mice (fsn/fsn), a 
spontaneously developing psoriasis-like mouse model, neutrophils were proposed 
to be pro-inflammatory and to promote psoriasis development. However, these 
conclusions were drowned based on the effect of neutrophil depletion or blockage 
of infiltration into the skin by injections of anti-GR-1 Ab (clone RB6-8C5) or 
anti-αMβ2 (CD11b/CD18; clone M1/70) Ab, respectively (Schon et al., 2000). As 
these types of interventions affect also several other subsets of myeloid cells, 
including monocytes/macrophages and DCs which also play a pivotal role in 
psoriasis development (Costa et al. 2017; Singh et al. 2016; Tortola et al. 2012; 
Christian Wohn et al. 2013), it is difficult to draw definitive conclusions on the 
specific role of neutrophils in this model. Similar to our work, two other studies 
have instead attempted to perform neutrophil depletion by utilizing the more 
specific anti-Ly6G Ab (clone 1A8) in the IMQ-induced mouse model of psoriasis 
(Singh et al. 2016; Sumida et al. 2014). However, while we found a protective role of 
neutrophils in this experimental model, in the study by Sumida H et al. (Sumida et 
al. 2014) neutrophils were shown to contribute to psoriasis development and in the 
study by Singh, T. et al (Singh et al. 2016) neutrophils were instead shown to not 
affect disease development. The reasons for these controversial results can be 
likely attributed to the fact that several variations to the original protocol for IMQ-
induced psoriasis (e.g. Aldara dosage, treatment of back skin versus ears, total 
days of treatment) have been utilized across different laboratories. We choose to 
perform the mostly utilized protocol originally published by van der Fits, L. et al 
(application of 60 mg of Aldara cream on the shaved back for 6 days (van der Fits 
et al. 2009). On the contrary, in the study performed by Sumida, H. et al. (Sumida et 
al. 2014), psoriasis was induced by applying a lower dose (30 mg) of Aldara cream 
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on the shaved back for 6 days, and in the study by Singh, T. et al. (Singh et al. 
2016) by applying 25 mg of Aldara cream on the ears for 4 days. In this context, it 
is noteworthy to remark that in our experimental conditions we did not observe 
any effect of neutrophil depletion on epidermal thickening after 3 days of IMQ 
treatment, likely because at this time point the number of neutrophils infiltrating 
the lymph nodes and skin was much lower than the one observed after 6 days of 
IMQ treatment. It is therefore possible that the lower dose and/or shorter protocol 
of Aldara cream utilized in the study by Sumida, H. et al. and by Singh, T. et al. 
may have induced a suboptimal neutrophil activation and infiltration into the skin, 
as compared to the one induced by our experimental protocol, leading therefore to 
different outcome on disease development after neutrophil depletion. In support of 
this hypothesis is the fact that, differently from our study, in the paper by Sumida, 
H. et al. the authors report a pick of neutrophil infiltration at 3 days after Aldara 
treatment with almost no neutrophil infiltration after 6 days (Sumida et al. 2014). 
The different housing conditions of the animal facilities may have also influenced 
the controversial results among the three studies. However, we tend to exclude 
this possibility as neutrophil-depleted mice treated with our experimental protocol 
of IMQ-induced psoriasis and housed in a different animal facility (University of 
California, San Francisco, USA) displayed a similar enhancement of epidermal 
thickening after 6 days of IMQ treatment (C.A. and C.A.L. unpublished 
observation).  
Despite these limitations, likely intrinsic to the peculiar experimental model and 
conditions utilized, we believe that the important message emerging from our 
study is that neutrophils may acquire a regulatory role during psoriasis 
development throughout their preferential interactions with γδ T cells. In this 
context, controversial observations are emerging also on the crosstalk occurring 
between neutrophils and γδ T cells (Kalyan & Kabelitz 2014; Scapini & Cassatella 
2014). For example, human neutrophils were initially shown to stimulate γδ T 
cells (Davey et al. 2011), while more recent evidence suggests that neutrophils 
negatively modulate spontaneous and phosphoantigen-induced γδ T-cell 
activation (Sabbione, María L Gabelloni, et al. 2014) or contribute to the loss of 
peripheral blood Vγ9Vδ2 T cells observed after long-term or high-dose 
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administration of zoledronate (Kalyan et al. 2014b). In mice, neutrophils were 
initially shown to inhibit γδ T cell functions in a mouse model of C. neoformans 
infection (Wozniak et al. 2012), while a more recent paper revealed that neutrophils 
can actually sustain IL-17 production by γδ T cells in the lung via IL-1β secretion 
in a NLRP3-inflammasome dependent manner during the initial phase of 
pneumococcal infection (Hassane et al. 2017). Different mechanisms have also been 
reported to mediate the interactions between neutrophils and γδ T cells. For 
instance human neutrophils have been reported to both promote (Towstyka et al. 
2017) and inhibit (Fazio et al. 2014) γδ T functions via the release of serine 
proteases. Similarly to what reported by Sabbione et al. (Sabbione, María L 
Gabelloni, et al. 2014) using human neutrophils, we found that the inhibitory effect 
of murine neutrophils on γδ T cells is mediated via cell-contact depended NADPH 
oxidase activation and ROS release.  
γδ T cells are known to be particularly susceptible to oxidative stress (Marlin et al. 
2017). Interestingly, several evidence support a contribution of IL-17 in Chronic 
Granulomatous Disease (CGD) mediated hyper-inflammation (Rieber et al. 2012) 
and susceptibility to autoimmune diseases  (De Ravin et al. 2008). Despite the fact 
that these phenomena have been so far mostly linked to an expansion of Th17 
lymphocytes (Horváth et al. 2011), the possible contribution of γδ T cells is also 
starting to emerge. In this context, a strong response of IL-17 producing γδ T cells 
was reported in p47phox
-/-
 mice infected with A. fumigatus (Romani et al. 2008).  
Relevant to our study is also the observation that p47phox
-/-
 mice were reported to 
develop enhanced IMQ-induced psoriasis (Kim et al. 2014). Future studies should 
further characterize the specific role of neutrophil-mediated inhibition of γδ T cell 
functions in this phenomenon.     
Overall this study proposes that neutrophils, instead of being promoters of 
inflammation as generally believed, can actually act as important negative 
regulators of the IMQ-mediated model of psoriasis. Considering that psoriasis 
consists of several different clinical phenotypes,  each of them characterized by 
distinct balance between autoimmune and auto-inflammatory immune processes, 
it may be worth to further verify the effective role of neutrophils also in human 
psoriasis. Neutrophils may indeed act as unexpected negative players of disease 
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development in specific types or clinical stages of human psoriasis. Consequently, 
also the utilization of therapeutic interventions targeted to inhibit neutrophil 
functions should be carefully evaluated. In this context, similarly to mouse 
psoriasis, the important role IL-17 producing γδ T cells in human psoriasis has 
just started to emerge (Cai et al. 2011; Laggner et al. 2011), indicating that possible 
inhibitory crosstalk between neutrophils and γδ T cells may exist also in human 
psoriasis and play a potential role in the modulation of disease development.  
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6.  Additional studies 
 
 
 
During my PhD I also participated to the following studies: 
 
Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: 
focus on innate myeloid cells. 
Costa S, Marini O, Bevilacqua D, DeFranco AL, Hou B, Lonardi S, Vermi W, Rodegher 
P, Panato A, Tagliaro F, Lowell CA, Cassatella MA, Girolomoni G, Scapini P. 
J Leukoc Biol. 2017 Sep;102(3):791-803. doi: 10.1189/jlb.3MA0217-054RR. Epub 2017 
Jun 22. 
 
Mature CD10
+
 and immature CD10
-
 neutrophils present in G-CSF-treated donors 
display opposite effects on T cells. 
Marini O, Costa S, Bevilacqua D, Calzetti F, Tamassia N, Spina C, De Sabata D, Tinazzi 
E, Lunardi C, Scupoli MT, Cavallini C, Zoratti E, Tinazzi I, Marchetta A, Vassanelli A, 
Cantini M, Gandini G, Ruzzenente A, Guglielmi A, Missale F, Vermi W, Tecchio C, 
Cassatella MA, Scapini P. 
Blood. 2017 Mar 9;129(10):1343-1356. doi: 10.1182/blood-2016-04-713206. Epub 2017 
Jan 4. 
. 
 
 
 
 
 
 
55 
 
7.  Bibliography 
 
 
 
Arakawa, A. et al., 2015. Melanocyte antigen triggers autoimmunity in human psoriasis. 
The Journal of experimental medicine, 212(13), pp.2203–12. 
Artis, D. & Spits, H., 2015. The biology of innate lymphoid cells. Nature, 517(7534), 
pp.293–301. 
Basavaraj, K.H. et al., 2010. The role of drugs in the induction and/or exacerbation of 
psoriasis. International Journal of Dermatology, 49(12), pp.1351–1361. 
Besgen, P. et al., 2010. Ezrin, maspin, peroxiredoxin 2, and heat shock protein 27: 
potential targets of a streptococcal-induced autoimmune response in psoriasis. 
Journal of immunology (Baltimore, Md. : 1950), 184(9), pp.5392–402. 
Beutner, K.R. & Ferenczy, A., 1997. Therapeutic approaches to genital warts. The 
American journal of medicine, 102(5A), pp.28–37. 
Bhushan, M. et al., 2002. Anti-E-selectin is ineffective in the treatment of psoriasis: a 
randomized trial. The British journal of dermatology, 146(5), pp.824–31. 
Bocheńska, K. et al., 2017. Models in the Research Process of Psoriasis. International 
journal of molecular sciences, 18(12), p.2514. 
Boehncke, W.-H. & Schön, M.P., 2015. Psoriasis. Lancet. 
Bos, J.D. et al., 2005. Psoriasis: dysregulation of innate immunity. British Journal of 
Dermatology, 152(6), pp.1098–1107. 
Bowcock, A.M., 2005. The genetics of psoriasis and autoimmunity. Annual review of 
genomics and human genetics, 6(1), pp.93–122. 
Bugl, S. et al., 2012. Current insights into neutrophil homeostasis. Annals of the New 
York Academy of Sciences, 1266(1), pp.171–178. 
Cai, Y. et al., 2011. Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin 
Inflammation. Immunity, 35(4), pp.596–610. 
Chan, J.R. et al., 2006. IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-
dependent mechanisms with implications for psoriasis pathogenesis. The Journal of 
experimental medicine, 203(12), pp.2577–87. 
Chen, M. et al., 2008. The methylation pattern of p16 
INK4a
 gene promoter in psoriatic 
epidermis and its clinical significance. British Journal of Dermatology, 158(5), 
pp.987–993. 
56 
 
Chien, Y., Meyer, C. & Bonneville, M., 2014. γδ T Cells: First Line of Defense and 
Beyond. Annual Review of Immunology, 32(1), pp.121–155. 
Chiricozzi, A. et al., 2011. Integrative Responses to IL-17 and TNF-α in Human 
Keratinocytes Account for Key Inflammatory Pathogenic Circuits in Psoriasis. 
Journal of Investigative Dermatology, 131(3), pp.677–687. 
Choi, J. et al., 2012. CD15+/CD16low human granulocytes from terminal cancer patients: 
granulocytic myeloid-derived suppressor cells that have suppressive function. 
Tumour biology : the journal of the International Society for Oncodevelopmental 
Biology and Medicine, 33(1), pp.121–9. 
Christophers, E., 2001. Psoriasis--epidemiology and clinical spectrum. Clinical and 
experimental dermatology, 26(4), pp.314–20. 
Coimbra, S. et al., 2012. The roles of cells and cytokines in the pathogenesis of psoriasis. 
International Journal of Dermatology, 51(4), pp.389–398. 
Costa, S. et al., 2017. Role of MyD88 signaling in the imiquimod-induced mouse model 
of psoriasis: focus on innate myeloid cells. Journal of leukocyte biology, 102(3), 
pp.791–803. 
Davey, M.S. et al., 2011. Human Neutrophil Clearance of Bacterial Pathogens Triggers 
Anti-Microbial γδ T Cell Responses in Early Infection E. J. Wherry, ed. PLoS 
Pathogens, 7(5), p.e1002040. 
Davey, M.S. et al., 2014. Microbe-specific unconventional T cells induce human 
neutrophil differentiation into antigen cross-presenting cells. Journal of immunology 
(Baltimore, Md. : 1950), 193(7), pp.3704–3716. 
Deng, Y., Chang, C. & Lu, Q., 2016. The Inflammatory Response in Psoriasis: a 
Comprehensive Review. Clinical Reviews in Allergy & Immunology, 50(3), pp.377–
389. 
Diani, M., Altomare, G. & Reali, E., 2015. T cell responses in psoriasis and psoriatic 
arthritis. Autoimmunity reviews, 14(4), pp.286–92. 
Dyring-Andersen, B. et al., 2017. Interleukin (IL)-17A and IL-22-producing neutrophils 
in psoriatic skin. The British journal of dermatology. 
Eberle, F.C. et al., 2016. Recent advances in understanding psoriasis. F1000Research, 5. 
Ebert, L.M., Meuter, S. & Moser, B., 2006. Homing and function of human skin 
gammadelta T cells and NK cells: relevance for tumor surveillance. Journal of 
immunology (Baltimore, Md. : 1950), 176(7), pp.4331–6. 
Elliott, E.R. et al., 2011. Deletion of Syk in neutrophils prevents immune complex 
arthritis. Journal of immunology (Baltimore, Md. : 1950), 187(8), pp.4319–30. 
57 
 
Fazio, J. et al., 2014. Inhibition of Human              γδ              T Cell Proliferation and 
Effector Functions by Neutrophil Serine Proteases. Scandinavian Journal of 
Immunology, 80(6), pp.381–389. 
van der Fits, L. et al., 2009. Imiquimod-Induced Psoriasis-Like Skin Inflammation in 
Mice Is Mediated via the IL-23/IL-17 Axis. The Journal of Immunology, 182(9), 
pp.5836–5845. 
Flutter, B. & Nestle, F.O., 2013a. TLRs to cytokines: Mechanistic insights from the 
imiquimod mouse model of psoriasis. European Journal of Immunology, 43(12), 
pp.3138–3146. 
Flutter, B. & Nestle, F.O., 2013b. TLRs to cytokines: Mechanistic insights from the 
imiquimod mouse model of psoriasis. European Journal of Immunology, 43(12), 
pp.3138–3146. 
Futosi, K., Fodor, S. & Mócsai, A., 2013. Neutrophil cell surface receptors and their 
intracellular signal transduction pathways. International immunopharmacology, 
17(3), pp.638–50. 
Granot, Z. & Jablonska, J., 2015. Distinct Functions of Neutrophil in Cancer and Its 
Regulation. Mediators of inflammation, 2015, p.701067. 
Gray, E.E. et al., 2013. Deficiency in IL-17-committed Vγ4(+) γδ T cells in a 
spontaneous Sox13-mutant CD45.1(+) congenic mouse substrain provides 
protection from dermatitis. Nature immunology, 14(6), pp.584–92. 
Gray, E.E., Suzuki, K. & Cyster, J.G., 2011. Cutting Edge: Identification of a Motile IL-
17-Producing    T Cell Population in the Dermis. The Journal of Immunology, 
186(11), pp.6091–6095. 
Griffiths, C.E. & Barker, J.N., 2007. Pathogenesis and clinical features of psoriasis. The 
Lancet, 370(9583), pp.263–271. 
Gudjonsson, J.E. et al., 2003. Streptococcal throat infections and exacerbation of chronic 
plaque psoriasis: a prospective study. The British journal of dermatology, 149(3), 
pp.530–4. 
Gunes, A.T. et al., 2015. Possible Triggering Effect of Influenza Vaccination on 
Psoriasis. Journal of Immunology Research, 2015, pp.1–4. 
Haas, J.D. et al., 2009. CCR6 and NK1.1 distinguish between IL-17A and IFN-γ-
producing γδ effector T cells. European Journal of Immunology, 39(12), pp.3488–
3497. 
Haas, J.D. et al., 2012. Development of Interleukin-17-Producing γδ T Cells Is Restricted 
to a Functional Embryonic Wave. Immunity, 37(1), pp.48–59. 
58 
 
Hartwig, T. et al., 2015. Dermal IL-17-producing γδ T cells establish long-lived memory 
in the skin. European Journal of Immunology, 45(11), pp.3022–3033. 
Hassane, M. et al., 2017. Neutrophilic NLRP3 inflammasome-dependent IL-1β secretion 
regulates the γδT17 cell response in respiratory bacterial infections. Mucosal 
immunology, 10(4), pp.1056–1068. 
Havran, W.L. & Jameson, J.M., 2010. Epidermal T Cells and Wound Healing. The 
Journal of Immunology, 184(10), pp.5423–5428. 
Hawkes, J.E., Gudjonsson, J.E. & Ward, N.L., 2017. The Snowballing Literature on 
Imiquimod-Induced Skin Inflammation in Mice: A Critical Appraisal. The Journal 
of investigative dermatology, 137(3), pp.546–549. 
Hemmi, H. et al., 2002. Small anti-viral compounds activate immune cells via the TLR7 
MyD88–dependent signaling pathway. Nature Immunology, 3(2), pp.196–200. 
Henry, C.M. et al., 2016. Neutrophil-Derived Proteases Escalate Inflammation through 
Activation of IL-36 Family Cytokines. Cell reports, 14(4), pp.708–722. 
Horváth, R. et al., 2011. Expansion of T helper type 17 lymphocytes in patients with 
chronic granulomatous disease. Clinical and experimental immunology, 166(1), 
pp.26–33. 
Jackson, S.H., Gallin, J.I. & Holland, S.M., 1995. The p47phox mouse knock-out model 
of chronic granulomatous disease. The Journal of experimental medicine, 182(3), 
pp.751–8. 
Jameson, J. et al., 2002. A Role for Skin gamma delta T Cells in Wound Repair. Science, 
296(5568), pp.747–749. 
Jariwala, S.P., 2007. The role of dendritic cells in the immunopathogenesis of psoriasis. 
Archives of Dermatological Research, 299(8), pp.359–366. 
Johnston, A. et al., 2017. IL-1 and IL-36 are dominant cytokines in generalized pustular 
psoriasis. The Journal of allergy and clinical immunology, 140(1), pp.109–120. 
Johnston, A. & Gudjonsson, J.E., 2014. 22 Again: IL-22 as a Risk Gene and Important 
Mediator in Psoriasis. Journal of Investigative Dermatology, 134(6), pp.1501–1503. 
Jones, H.R. et al., 2016. The role of neutrophils in inflammation resolution. Seminars in 
Immunology, 28(2), pp.137–145. 
Kalyan, S. et al., 2014a. Neutrophil uptake of nitrogen-bisphosphonates leads to the 
suppression of human peripheral blood γδ T cells. Cellular and molecular life 
sciences : CMLS, 71(12), pp.2335–46. 
Kalyan, S. et al., 2014b. Neutrophil uptake of nitrogen-bisphosphonates leads to the 
suppression of human peripheral blood γδ T cells. Cellular and molecular life 
59 
 
sciences : CMLS, 71(12), pp.2335–46. 
Kalyan, S. & Kabelitz, D., 2014. When neutrophils meet T cells: beginnings of a 
tumultuous relationship with underappreciated potential. European journal of 
immunology, 44(3), pp.627–33. 
Kanneganti, T.-D. et al., 2006. Bacterial RNA and small antiviral compounds activate 
caspase-1 through cryopyrin/Nalp3. Nature, 440(7081), pp.233–6. 
Kim, H.-R. et al., 2014. Reactive oxygen species prevent imiquimod-induced psoriatic 
dermatitis through enhancing regulatory T cell function. D. Unutmaz, ed. PloS one, 
9(3), p.e91146. 
Kimball, A.B. et al., 2005. The psychosocial burden of psoriasis. American journal of 
clinical dermatology, 6(6), pp.383–92. 
Kisielow, J., Kopf, M. & Karjalainen, K., 2008. SCART scavenger receptors identify a 
novel subset of adult gammadelta T cells. Journal of immunology (Baltimore, Md. : 
1950), 181(3), pp.1710–6. 
Kolaczkowska, E. & Kubes, P., 2013. Neutrophil recruitment and function in health and 
inflammation. Nature Reviews Immunology, 13(3), pp.159–175. 
Laggner, U. et al., 2011. Identification of a novel proinflammatory human skin-homing 
Vγ9Vδ2 T cell subset with a potential role in psoriasis. Journal of immunology 
(Baltimore, Md. : 1950), 187(5), pp.2783–93. 
Ley, K., Smith, E. & Stark, M.A., 2006. Neutrophil-Regulatory Tn Lymphocytes. 
Immunologic Research, 34(3), pp.229–242. 
Liang, W. & Ferrara, N., 2016. The Complex Role of Neutrophils in Tumor Angiogenesis 
and Metastasis. Cancer immunology research, 4(2), pp.83–91. 
Lieschke, G.J. et al., 1994. Mice lacking granulocyte colony-stimulating factor have 
chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and 
impaired neutrophil mobilization. Blood, 84(6), pp.1737–46. 
Lin, A.M. et al., 2011. Mast cells and neutrophils release IL-17 through extracellular trap 
formation in psoriasis. Journal of immunology (Baltimore, Md. : 1950), 187(1), 
pp.490–500. 
Lowes, M.A. et al., 2008. Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 
and Th17 T Cells. Journal of Investigative Dermatology, 128(5), pp.1207–1211. 
Macleod, T. et al., 2016. Neutrophil Elastase-mediated proteolysis activates the anti-
inflammatory cytokine IL-36 Receptor antagonist. Scientific Reports, 6(1), p.24880. 
Mantovani, A. et al., 2011. Neutrophils in the activation and regulation of innate and 
adaptive immunity. Nature Reviews Immunology, 11(8), pp.519–531. 
60 
 
Marini, O. et al., 2017. Mature CD10 
+
 and immature CD10 
−
 neutrophils present in G-
CSF–treated donors display opposite effects on T cells. Blood, 129(10), pp.1343–
1356. 
Marlin, R. et al., 2017. Sensing of cell stress by human γδ TCR-dependent recognition of 
annexin A2. Proceedings of the National Academy of Sciences of the United States 
of America, 114(12), pp.3163–3168. 
McLaughlin, F. & La Thangue, N.B., 2004. Histone deacetylase inhibitors in psoriasis 
therapy. Current drug targets. Inflammation and allergy, 3(2), pp.213–9. 
Mestas, J. & Hughes, C.C.W., 2004. Of mice and not men: differences between mouse 
and human immunology. Journal of immunology (Baltimore, Md. : 1950), 172(5), 
pp.2731–8. 
Mócsai, A., 2013. Diverse novel functions of neutrophils in immunity, inflammation, and 
beyond. The Journal of experimental medicine, 210(7), pp.1283–99. 
Mócsai, A. et al., 2002. Syk is required for integrin signaling in neutrophils. Immunity, 
16(4), pp.547–58. 
Moses, K. & Brandau, S., 2016. Human neutrophils: Their role in cancer and relation to 
myeloid-derived suppressor cells. Seminars in immunology, 28(2), pp.187–96. 
Muñoz-Ruiz, M. et al., 2017. Thymic Determinants of γδ T Cell Differentiation. Trends 
in Immunology, 38(5), pp.336–344. 
Nathan, C., 2006. Neutrophils and immunity: challenges and opportunities. Nature 
Reviews Immunology, 6(3), pp.173–182. 
Nestle, F.O., Kaplan, D.H. & Barker, J., 2009. Psoriasis. New England Journal of 
Medicine, 361(5), pp.496–509. 
O‟Brien, R.L. & Born, W.K., 2015. Dermal γδ T cells--What have we learned? Cellular 
immunology, 296(1), pp.62–9. 
Ortega, C. et al., 2009. IL-17-producing CD8+ T lymphocytes from psoriasis skin 
plaques are cytotoxic effector cells that secrete Th17-related cytokines. Journal of 
leukocyte biology, 86(2), pp.435–43. 
Pai, S. et al., 1999. Clearance of psoriasis following agranulocytosis. International 
journal of dermatology, 38(11), pp.876–70. 
Pantelyushin, S. et al., 2012. Rorγt+ innate lymphocytes and γδ T cells initiate 
psoriasiform plaque formation in mice. The Journal of clinical investigation, 122(6), 
pp.2252–6. 
Papotto, P.H. et al., 2017. Innately versatile: γδ17 T cells in inflammatory and 
autoimmune diseases. Journal of autoimmunity. 
61 
 
Pasić, A. et al., 2009. The genetics of psoriasis--selected novelties in 2008. Acta 
dermatovenerologica Croatica : ADC, 17(3), pp.176–81. 
Pelletier, M. et al., 2010. Evidence for a cross-talk between human neutrophils and Th17 
cells. Blood, 115(2), pp.335–343. 
Perera, G.K., Di Meglio, P. & Nestle, F.O., 2012. Psoriasis. Annual Review of Pathology: 
Mechanisms of Disease, 7(1), pp.385–422. 
Pillay, J. et al., 2012. A subset of neutrophils in human systemic inflammation inhibits T 
cell responses through Mac-1. Journal of Clinical Investigation, 122(1), pp.327–
336. 
Pillay, J. et al., 2010. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 
5.4 days. Blood, 116(4), pp.625–627. 
Rabeony, H. et al., 2015. IMQ-induced skin inflammation in mice is dependent on IL-
1R1 and MyD88 signaling but independent of the NLRP3 inflammasome. European 
journal of immunology, 45(10), pp.2847–57. 
Ramírez-Valle, F., Gray, E.E. & Cyster, J.G., 2015. Inflammation induces dermal Vγ4 + 
γδT17 memory-like cells that travel to distant skin and accelerate secondary IL-17–
driven responses. Proceedings of the National Academy of Sciences, 112(26), 
pp.8046–8051. 
De Ravin, S.S. et al., 2008. Chronic granulomatous disease as a risk factor for 
autoimmune disease. Journal of Allergy and Clinical Immunology, 122(6), pp.1097–
1103. 
Raychaudhuri, S.P. & Gross, J., 2000. A comparative study of pediatric onset psoriasis 
with adult onset psoriasis. Pediatric dermatology, 17(3), pp.174–8. 
Ribot, J.C. et al., 2012. B7-CD28 Costimulatory Signals Control the Survival and 
Proliferation of Murine and Human    T Cells via IL-2 Production. The Journal of 
Immunology, 189(3), pp.1202–1208. 
Rieber, N. et al., 2012. Current concepts of hyperinflammation in chronic granulomatous 
disease. Clinical & developmental immunology, 2012, p.252460. 
Roark, C.L. et al., 2007. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-
producing gamma delta T cells. Journal of immunology (Baltimore, Md. : 1950), 
179(8), pp.5576–83. 
Romani, L. et al., 2008. Defective tryptophan catabolism underlies inflammation in 
mouse chronic granulomatous disease. Nature, 451(7175), pp.211–5. 
Ruchusatsawat, K. et al., 2006. SHP-1 promoter 2 methylation in normal epithelial tissues 
and demethylation in psoriasis. Journal of Molecular Medicine, 84(2), pp.175–182. 
62 
 
Sabbione, F., Gabelloni, M.L., et al., 2014. Neutrophils suppress γδ T-cell function. 
European Journal of Immunology, 44(3), pp.819–830. 
Sabbione, F., Gabelloni, M.L., et al., 2014. Neutrophils suppress γδ T-cell function. 
European journal of immunology, 44(3), pp.819–30. 
Sagi, L. & Trau, H., 2011. The Koebner phenomenon. Clinics in Dermatology, 29(2), 
pp.231–236. 
Scapini, P. et al., 2011. B cell-derived IL-10 suppresses inflammatory disease in Lyn-
deficient mice. Proceedings of the National Academy of Sciences, 108(41), 
pp.E823–E832. 
Scapini, P. et al., 2016. Human neutrophils in the saga of cellular heterogeneity: insights 
and open questions. Immunological Reviews, 273(1), pp.48–60. 
Scapini, P. & Cassatella, M.A., 2014. Social networking of human neutrophils within the 
immune system. Blood, 124(5), pp.710–9. 
Schmielau, J. & Finn, O.J., 2001. Activated granulocytes and granulocyte-derived 
hydrogen peroxide are the underlying mechanism of suppression of t-cell function 
in advanced cancer patients. Cancer research, 61(12), pp.4756–60. 
Schön, M. et al., 2000. Critical role of neutrophils for the generation of psoriasiform skin 
lesions in flaky skin mice. Journal of Investigative Dermatology, 114(5), pp.976–
983. 
Schön, M.P., Broekaert, S.M.C. & Erpenbeck, L., 2017. Sexy again: the renaissance of 
neutrophils in psoriasis. Experimental dermatology, 26(4), pp.305–311. 
Schön, M.P., Schön, M. & Klotz, K.-N., 2006. The small antitumoral immune response 
modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and 
TLR8-independent fashion. The Journal of investigative dermatology, 126(6), 
pp.1338–47. 
Shaul, M.E. & Fridlender, Z.G., 2017. Neutrophils as active regulators of the immune 
system in the tumor microenvironment. Journal of leukocyte biology, 102(2), 
pp.343–349. 
Silvestre-Roig, C., Hidalgo, A. & Soehnlein, O., 2016. Neutrophil heterogeneity: 
implications for homeostasis and pathogenesis. Blood, 127(18), pp.2173–81. 
Singh, T.P. et al., 2016. Monocyte-derived inflammatory Langerhans cells and dermal 
dendritic cells mediate psoriasis-like inflammation. Nature Communications, 7, 
p.13581. 
Sinkora, M., Sinkorova, J. & Holtmeier, W., 2005. Development of gammadelta 
thymocyte subsets during prenatal and postnatal ontogeny. Immunology, 115(4), 
63 
 
pp.544–555. 
Soehnlein, O. et al., 2017. Neutrophils as protagonists and targets in chronic 
inflammation. Nature Reviews Immunology, 17(4), pp.248–261. 
Sonkoly, E. et al., 2007. MicroRNAs: novel regulators involved in the pathogenesis of 
psoriasis? J. Zimmer, ed. PloS one, 2(7), p.e610. 
Stadtmann, A. et al., 2013. The PSGL-1-L-selectin signaling complex regulates 
neutrophil adhesion under flow. The Journal of experimental medicine, 210(11), 
pp.2171–80. 
Stark, M.A. et al., 2005. Phagocytosis of Apoptotic Neutrophils Regulates Granulopoiesis 
via IL-23 and IL-17. Immunity, 22(3), pp.285–294. 
Sumida, H. et al., 2014. Interplay between CXCR2 and BLT1 Facilitates Neutrophil 
Infiltration and Resultant Keratinocyte Activation in a Murine Model of Imiquimod-
Induced Psoriasis. Journal of immunology (Baltimore, Md. : 1950), 192(9), 
pp.4361–9. 
Sutton, C.E. et al., 2009. Interleukin-1 and IL-23 Induce Innate IL-17 Production from γδ 
T Cells, Amplifying Th17 Responses and Autoimmunity. Immunity, 31(2), pp.331–
341. 
Tamassia, N., Cassatella, M.A. & Bazzoni, F., 2014. Fast and accurate quantitative 
analysis of cytokine gene expression in human neutrophils. Methods in molecular 
biology (Clifton, N.J.), 1124, pp.451–67. 
Tecchio, C. & Cassatella, M.A., 2016. Neutrophil-derived chemokines on the road to 
immunity. Seminars in Immunology, 28(2), pp.119–128. 
Toichi, E., Tachibana, T. & Furukawa, F., 2000. Rapid improvement of psoriasis vulgaris 
during drug-induced agranulocytosis. Journal of the American Academy of 
Dermatology, 43(2 Pt 2), pp.391–5. 
Tonel, G. et al., 2010. Cutting edge: A critical functional role for IL-23 in psoriasis. 
Journal of immunology (Baltimore, Md. : 1950), 185(10), pp.5688–91. 
Tortola, L. et al., 2012. Psoriasiform dermatitis is driven by IL-36-mediated DC-
keratinocyte crosstalk. The Journal of clinical investigation, 122(11), pp.3965–76. 
Tovar-Castillo, L.E. et al., 2007. Under-expression of VHL and over-expression of 
HDAC-1, HIF-1alpha, LL-37, and IAP-2 in affected skin biopsies of patients with 
psoriasis. International journal of dermatology, 46(3), pp.239–46. 
Towstyka, N.Y. et al., 2017. Modulation of γδ T-cell activation by neutrophil elastase. 
Immunology. 
Tsoi, L.C. et al., 2012. Identification of 15 new psoriasis susceptibility loci highlights the 
64 
 
role of innate immunity. Nature Genetics, 44(12), pp.1341–1348. 
Wilson, N.J. et al., 2007. Development, cytokine profile and function of human 
interleukin 17-producing helper T cells. Nature immunology, 8(9), pp.950–7. 
Wohn, C. et al., 2013. Langerin(neg) conventional dendritic cells produce IL-23 to drive 
psoriatic plaque formation in mice. Proceedings of the National Academy of 
Sciences of the United States of America, 110(26), pp.10723–8. 
Wohn, C. et al., 2013. Langerinneg conventional dendritic cells produce IL-23 to drive 
psoriatic plaque formation in mice. Proceedings of the National Academy of 
Sciences, 110(26), pp.10723–10728. 
Wozniak, K.L., Kolls, J.K. & Wormley, F.L., 2012. Depletion of neutrophils in a 
protective model of pulmonary cryptococcosis results in increased IL-17A 
production by γδ T cells. BMC immunology, 13, p.65. 
Wu, J.K., Siller, G. & Strutton, G., 2004. Psoriasis induced by topical imiquimod. The 
Australasian journal of dermatology, 45(1), pp.47–50. 
Yoshiki, R. et al., 2014. IL-23 from Langerhans cells is required for the development of 
imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing γδ T 
cells. The Journal of investigative dermatology, 134(7), pp.1912–1921. 
Zaba, L.C., Krueger, J.G. & Lowes, M.A., 2009. Di cesare 2009. The Journal of 
investigative dermatology, 129(2), pp.302–8. 
Zabieglo, K. et al., 2015. The inhibitory effect of secretory leukocyte protease inhibitor 
(SLPI) on formation of neutrophil extracellular traps. Journal of Leukocyte Biology, 
98(1), pp.99–106. 
Zhang, P. et al., 2011. Abnormal histone modifications in PBMCs from patients with 
psoriasis vulgaris. European journal of dermathology, 21(4), pp.552–557. 
Van Ziffle, J.A. & Lowell, C.A., 2009. Neutrophil-specific deletion of Syk kinase results 
in reduced host defense to bacterial infection. Blood, 114(23), pp.4871–4882. 
 
 
 
